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Abstract
The Biomarkers of Nutrition for Development (BOND) project is designed to provide evidence-informed advice to anyonewith
an interest in the role of nutrition in health. The BOND program provides information with regard to selection, use, and
interpretation of biomarkers of nutrient exposure, status, function, and effect, which will be especially useful for readers who
want to assess nutrient status. To accomplish this objective, expert panels are recruited to evaluate the literature and to draft
comprehensive reports on the current state of the art with regard to specific nutrient biology and available biomarkers for
assessing nutritional status at the individual and population levels. Phase I of the BOND project includes the evaluation of
biomarkers for 6 nutrients: iodine, folate, zinc, iron, vitamin A, and vitamin B-12. This review of vitamin A is the current article
in this series. Although the vitamin was discovered >100 y ago, vitamin A status assessment is not trivial. Serum retinol
concentrations are under homeostatic control due in part to vitamin As use in the body for growth and cellular differentiation
and because of its toxic properties at high concentrations. Furthermore, serum retinol concentrations are depressed during
infection and inflammation because retinol-binding protein (RBP) is a negative acute-phase reactant, which makes status
assessment challenging. Thus, this review describes the clinical and functional indicators related to eye health and
biochemical biomarkers of vitamin A status (i.e., serum retinol, RBP, breast-milk retinol, dose-response tests, isotope dilution
methodology, and serum retinyl esters). These biomarkers are then related to liver vitamin A concentrations, which are
usually considered the gold standard for vitamin A status. With regard to biomarkers, future research questions and gaps in
our current understanding as well as limitations of the methods are described. J Nutr 2016;146(Suppl):1816S–48S.
Keywords: BOND, vitamin A biomarkers, vitamin A review, breast milk, dose response tests, dried blood spot,
isotope dilution, retinol-binding protein, serum retinol, xerophthalmia
Introduction
Vitamin A, a term encompassing a group of unsaturated organic
compounds, which include retinol, retinal, and retinoic acid
(Figure 1), is an essential nutrient because it cannot be produced
by humans and must be provided as part of the diet. Provitamin
A carotenoids, which are produced in plants, are also a primary
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dietary source of the vitamin after enzymatic cleavage. Vitamin
A deficiency continues to contribute significantly to the global
burden of disease, particularly affecting resource-constrained coun-
tries (1). Vitamin A deficiency disorders include xerophthalmia and
increased risk of death from infectious diseases, especially among
preschool children. The current state of the science and challenges
for assessing vitaminA status at the individual and population levels
are the focus of this review.
Historical overview. The history of our knowledge of vitamin
A spans centuries, although its chemical properties, biochemical
functions, and global significance have come to light over the past
century (2–46) (Table 1). In addition to the review article by Wolf
(2), other comprehensive historical overviews have been published
(21, 47, 48). Xerophthalmia, a spectrum of ocular manifestations
resulting from vitamin A deficiency, has been known for$3500 y
and was treated in ancient Assyria, Egypt, and Greece with foods
now known to be rich in preformed vitamin A esters (2). The
earliest association between nightblindness and a corneal defect
was made by von Hubbenet in 1860, followed by the character-
ization of conjunctival xerosis with foamy white spots on the
cornea by Bitot in 1862 (2, 3), now known as ‘‘Bitots spots’’ and
regarded as a strong clinical indicator of vitamin A deficiency,
which is usually reversible with vitamin A supplementation.
Although deficiency is the primary public health focus and the
WHOadvocates high-dose vitamin A supplements to select groups
(38–42) (Table 2), it is well recognized that vitamin A excess is also
a consideration. Bone abnormalities in fossilized skeletal remains
of early humans may have been caused by excessive preformed
vitamin A intakes (49, 50), suggesting that vitamin A toxicity may
also have been an ancient phenomenon (51). Vitamin A has been
referred to as the ‘‘luxus’’ vitamin in the past, suggesting that excessive
intake habitually exists among some individuals (52), reinforcing the
point that maintaining balance is important for overall health (53).
As highlighted in Table 1, over the past 100 y, vitamin A was
chemically identified, purified, and synthesized and its clinical
relevance and molecular importance were discovered. These find-
ings have had important implications for global efforts to prevent
blindness and mitigate mortality risk through large-scale supple-
mentation efforts. However, our understanding of its role in fat
metabolism, immune function, and epigenetic gene regulation is still
evolving (54). The simultaneous discovery of retinoic acid receptors
(RARs)13 by Chambons group in Strasbourg, France (24), Evans
group in San Diego, California (25), and Pfahls group in La Jolla,
California (26), in the 1980s opened up new research areas that
helped to expand our understanding of the molecular actions and
functions of vitamin A (2).
FIGURE 1 The structures of the
major dietary forms of vitamin A.
Preformed retinol is primarily
found as retinyl palmitate in most
animal livers, fortificants, and sup-
plements. From ;50 provitamin A
carotenoids in plants, the common
ones include a-carotene, b-carotene,
and b-cryptoxanthin. These forms
of provitamin A carotenoids are
often quantified in human serum.
13 Abbreviations used: AGP, a1-acid glycoprotein; BCO1, b-carotene 15,15#
dioxygenase; BCO2, b-carotene 9,10-oxygenase; BOND, Biomarkers of Nutrition for
Development; CRP,C-reactive protein; DBS, dried blood spot; DR, 3,4-didehydroretinol;
DRA, 3,4-didehydroretinyl acetate; IOM, Institute of Medicine; ISX, intestine-specific
homeobox transcription factor; log cd, log candela; LRAT, lecithin:retinol acyltransfer-
ase; MRDR, modified relative dose response; Raldh1, retinaldehyde dehydrogenase
1; RAR, retinoic acid receptor; RBP, retinol-binding protein; RDR, relative dose
response; STRA6, stimulated by retinoic acid 6 receptor; Th, T-helper; TSHB, pituitary
thyroid-stimulating hormone b gene; UL, Tolerable Upper Intake Level.
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Exposure: food sources. Sources of vitamin A are required
throughout the life cycle. During infancy, colostrum and mature
human milk are rich sources of both preformed vitamin A and
provitamin A carotenoids, especially when the mother has
adequate dietary intake (55) as recommended by dietary
guidelines (56). Beyond infancy, vitamin A is consumed in the
diet as preformed retinyl esters, predominantly retinyl palmitate
(Figure 1), from animal sources. It is also provided by provita-
min A carotenoids, such as b-carotene and b-cryptoxanthin
(Figure 1), primarily from plant sources (57, 58).
Fortified foods in both developed and developing countries
can serve as important dietary sources of preformed vitamin A. In
developed countries, these foods include ready-to-eat cereals,
snack foods, beverages, margarine, and processed dairy products
(59). In developing countries, vitamin A–fortified foods, although
limited, include sugar, cereal flours, edible oils (59, 60), margarine
(61), and noodles (62). TheWHOhas developed guidelines for the
fortification of foods with micronutrients (63).
In addition to these food-based sources, vitamin A may be
provided alone or as a component of multivitamin dietary sup-
plements. Both preformed vitamin A (predominantly as either
retinyl acetate or palmitate) and provitamin A (predominantly as
b-carotene) are used in commercial dietary supplements (64).
Dietary and supplemental sources of preformed vitamin A and
provitamin A carotenoids are highlighted in Text Box 1.
Intakes in developed countries of preformed retinol tend to be
higher than in developing countries where provitamin A carote-
noids represent the major source of dietary vitamin A. Children
and teenagers in the United States derive >80% of their vitamin A
as preformed vitamin A and average adult estimates are >65%
(65). In comparison, Ugandan preschool children consume 5–25%
and adults consume 5–20% as preformed vitamin A (66). China
appears to lie in the middle with a reference intake of;50% from
preformed retinol sources (after recalculating a bioconversion
factor of 6- to 12-mg b-carotene equivalents to 1 mg retinol for com-
parison purposes) (67). In addition to b-carotene, b-cryptoxanthin,
TABLE 1 Historical accounts in the discovery and history of vitamin A research and biomarker development1
Year Discovery
460–325 BC Ancient Egyptians and Greeks cured nightblindness with roasted oxen liver (2)
1860–1863 von Hubbenet associated nightblindness with eye defects and Bitot described conjunctival xerosis by identifying ``Bitots spots ` `(reviewed in references 2 and 3)
1861 Schwarz diagnosed nightblindness as a nutritional disease during a naval expedition (reviewed in reference 2)
1904 Mori reported ``Hikan ` `in Japanese children, which responded to cod liver oil and liver (reviewed in reference 2)
1913 McCollum and Davis (4) and Osborne and Mendel (5) discovered ``fat-soluble A ` `in rat feeding studies
1919 Bloch (6) found xerophthalmia in Danish orphans subsisting on a fat-free milk, oatmeal, and barley diet
1919–1920 Steenbock and Gross (7, 8) identified a yellow pigment (b-carotene) that was converted to active colorless vitamin A
1928 Green and Melanby (9) first coined the term ``anti-infective ` `for vitamin A
1930 Moore (10) purified yellow pigment from plants, butter fat, and egg yolk as carotene and showed that it was converted to vitamin A
1931 Karrer et al. (11) isolated and described the chemical structures of retinol and b-carotene (Figure 1)
1931 Green et al. (12) showed that cod liver oil reduces puerperal fever
1932 Ellison (13) reported that vitamin A reduces measles fatality
1935 Wald (14) described ``the visual cycle ` `
1937 Holmes and Corbet (15) isolated and crystallized pure vitamin A from fish liver oil
1947 Isler et al. (16) synthesized retinol
1960 Gopalan et al. (17) drew global attention to endemic vitamin A deficiency in India
1965 Olson and Hayaishi (18) discovered b-carotene 15,15#-dioxygenase as the core enzyme in the conversion of provitamin A carotenoids to vitamin A in the intestine
1966 McLaren et al. (19) published detailed photo accounts of xerophthalmia
1967 Wald (20) received the Nobel Prize in physiology for describing the visual cycle
1974 The International Vitamin A Consultative Group was established (21)
1978 Loerch et al. (22) proposed the principle of the relative-dose-response test in rats
1986 Sommer et al. (23) reported that vitamin A can reduce child mortality in Indonesia followed by recommendations by UNICEF and WHO for the use of high-dose
vitamin A supplements (21)
1987–1988 Petkovich et al. (24), Giguere et al. (25), and Benbrooke et al. (26) simultaneously discovered the retinoic acid receptors in cell nuclei
1988 Tanumihardjo and Olson (27) proposed vitamin A2 in a modified-relative-dose-response test
1989 Furr et al. (28) published the use of deuterated retinyl acetate for vitamin A assessment of humans
1990 Beaton et al. (29) summarized 16 studies using vitamin A supplementation, concluding an average childhood mortality reduction of 23%
1992 At the International Conference on Nutrition in Rome, countries committed to preventing vitamin A deficiency (21)
1995 Bioavailability of provitamin A carotenoids in green leafy vegetables challenged by de Pee et al. (30) in Indonesia
1998 Christian et al. (31, 32) in Nepal revealed maternal nightblindness as an indicator of maternal vitamin A deficiency, poor health, and survival
1999 West et al. (33) in Nepal reported that vitamin A or b-carotene supplementation can lower maternal mortality
2001 The Institute of Medicine (34) in the United States revised the b-carotene:retinol bioconversion ratio from 6 μg b-carotene:1 μg retinol to 12:1 and the ratio for
other provitamin A carotenoids from 12:1 to 24:1
2003 Thurnham et al. (35) systematically showed the influence of inflammation on serum retinol concentrations
2003 Ramathullah et al. (36) reported from India a 23% reduction in infant mortality by giving newborns a single;50,000 IU oral dose of vitamin A, affirming earlier work
by Humphrey et al. (37) in Indonesia
2011 The WHO (38–42) revised vitamin A supplementation recommendations for women and children on the basis of the current evidence base
2013 Awasthi et al. (43) found a nonsignificant 4% decrease in mortality of Indian children given periodic 200,000-IU supplements
2014 Large randomized, double-blind, placebo-controlled trials in Ghana (44) and Tanzania (45) showed no impact, whereas India showed a 10% reduction (46) in infant
mortality after 50,000 IU vitamin A was administered at birth
1 Although comprehensive, the table does not include all of the important discoveries for applications of vitamin A.
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found predominantly in orange citrus fruit, some pumpkins,
and yellow/orange maize, is another common provitamin A
carotenoid and has similar bioefficacy to b-carotene in both
animals (68) and humans (69). Another common provitamin A
carotenoid often quantified in human serum is a-carotene, pre-
dominantly found in orange carrots and some pumpkins (58). Due
to its chemical structure (Figure 1), a-carotene theoretically yields
half the retinol that b-carotene does, which was demonstrated in a
gerbil model (70).
Absorption and bioavailability of provitamin A carotenoids.
Approximately 70–90% of preformed vitamin A esters are
absorbed and utilized or stored (71) (Figure 2), but the range
for absorption of dietary provitamin A carotenoids is much
wider. Provitamin A carotenoids can be found in either the
cis- or trans-configuration. Between 35% and 88% of absorbed
all-trans b-carotene is oxidatively cleaved by b-carotene 15,15’-
dioxygenase 1 (BCO1) into 2 molecules of all-trans retinal in
the enterocyte (18, 72), which can be oxidized irreversibly to
retinoic acid by 1 of 3 retinal dehydrogenases or reduced revers-
ibly to retinol by a number of retinal reductases (73, 74). The cis
isomers must be isomerized to the all-trans configuration before
BCO1 can cleave them, resulting in lower bioconversion effi-
ciency (56, 75). Retinoic acid can also be formed by an excentric
cleavage pathway mediated by the enzyme b-carotene 9,10-
oxygenase (BCO2). This, however, represents a minor pathway
for b-carotene cleavage (76).
A number of studies in developing countries examined the
bioavailability of b-carotene from individual vegetables and fruit.
The bioavailability and bioconversion were low from vegetables
(30, 77) and better from orange fruit (78). The determining
bioaccessibility factor (i.e., release from the plant matrix) influ-
encing the bioavailability appears to be the location of carotenoids
within the chromoplast as opposed to the chloroplasts. In addi-
tion, the crystalline form, such as carotene crystals in carrots, may
also negatively affect overall bioavailability (79). Cooking and heat
processing also disrupt the plant matrix (80), and these processes
usually result in greater bioavailability (79).
As a consequence of this complex and variable absorption
process, concerns have been raised with regard to populations
who are largely dependent on vegetables and fruit to meet
dietary vitamin A requirements (77). Current studies have raised
questions about this premise based largely on methods used to
assess conversion and subsequent storage of vitamin A from
plant sources. For example, by using a sensitive stable isotope
dilution methodology, green and yellow vegetables were able to
maintain total body vitamin A stores in Chinese children during
a 10-wk intervention (81). Furthermore, stable isotope meth-
odologies have shown a wide range for b-carotene conversion
from different plant sources (82–85). The bioconversion mass
ratio of b-carotene equivalents in various food matrices to yield
1 mg vitamin A ranged from high values of 21:1 in spinach and
15:1 in carrots (82), moderate values of 13:1 for sweet potatoes,
and 10:1 for pureed spinach (83) and low values of ;2:1 in
genetically engineered Golden rice (84). In part, these ranges
may be due to differences in initial vitamin A status among study
participants such that vitamin A–deficient individuals may
cleave provitamin A carotenoids at a higher rate, resulting in
greater bioefficacy (79).
Given the evidence of poor provitamin A carotenoid bio-
availability from green leafy and some other vegetables, a range
of approaches to improve vitamin A status through diet have
been proposed (79, 86–88) including the following:
· promotion of food sources of preformed vitamin A (e.g.,
animal and fortified foods),
· promotion of a wider variety of high provitamin A
carotenoid–containing foods, including biofortified staples,
and
· food preparation methods that enhance carotenoid absorp-
tion.
Individually or in combination, these approaches offer practical
tactics for improving vitamin A status (89).
Fortification efforts with preformed vitamin A. Food forti-
fication with preformed vitamin A is a viable option that can be
2–4 times more cost-effective in providing vitamin A than either
capsule distribution with preformed retinyl palmitate or dietary
diversification efforts (63). Fortification with vitamin A has been
used successfully in the developed world for >80 y, and its
potential was recognized in the developing world 40 y ago (59).
In general, food fortification with vitamin A has the advantages
of being socially acceptable and requiring minimal changes in
food habits.
The implementation of fortification in some areas has been
slow due to lack of centralized processing of potential food
vehicles (59). Nonetheless, there have been notable successes
[e.g., vitamin A fortification of sugar in Guatemala and other
Central American countries (59, 90)]. Fortification needs to
satisfy certain specifications to be effective at the population
level (Table 3). Each country should evaluate which approach or
TABLE 2 The WHOs vitamin A supplementation recommen-
dations based on evidence to reduce infant and maternal
morbidity and mortality as of 20111
Age group and vitamin A dosage2 Frequency
Neonatal Not recommended
Age 1–5 mo Not recommended
Age 6–11 mo
100,000 IU One-time dose
Age 12–59 mo
200,000 IU Every 4–6 mo
Postpartum women Not recommended
Pregnant women Routinely not recommended
10,000 IU Daily in at-risk areas for nightblindness
25,000 IU Weekly in at-risk areas for nightblindness
1 Data are from references 38–42.
2 Dosages are listed in International Units (IU) of vitamin A.
Text Box 1 Food and Supplemental Sources High in
Vitamin A
Preformed vitamin A in foods
d liver
d fish liver oils
d dairy products: butter, cheese, milk fat, other dairy
products
d egg yolk
Provitamin A carotenoids in plant foods
d dark-green leafy vegetables
d deeply colored yellow and orange vegetables and fruit
Supplemental vitamin A
d preformed retinyl acetate or palmitate
d b-carotene in some multivitamins
d b-carotene
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approaches (i.e., dietary diversification, biofortification, fortifi-
cation, and/or supplementation) provide the greatest benefit for
investment with available resources and whether the most
vulnerable population groups are reached by the proposed
approach or approaches, such as was shown in Zambia (91).
Public health significance. In 2009, the WHO estimated that
5.2 million preschool children and 9.8 million pregnant women
were affected with nightblindness, which corresponds to 0.9%
and 7.8% prevalence of vitamin A deficiency, respectively (1). It
has also been estimated that based on the currently accepted
cutoff for low serum retinol concentrations (<0.7 mmol/L), 190
million preschool children and 19.1 million pregnant women
globally are affected. These estimates correspond to 33.3% of
the preschool population and 15.3% of pregnant women in
populations at risk of vitamin A deficiency. Africa and Southeast
Asia are the most affected by vitamin A deficiency for both
population groups (1) (Table 4).
Although body vitamin A stores increase toward normal
values during infancy in well-nourished societies (92), the status
of infants reared under vitamin A–deprived and infection-
exposed conditions tends to remain depressed (93). It is common
for vitamin A deficiency to extend into the adolescent years. For
example, in Southeast Asia, 23% of children aged 5–15 y had
serum retinol concentrations <0.7 mmol/L, although inflammation
markers were not measured, and nearly 3% presented with
nonblinding, mild xerophthalmia (94).
Women of child-bearing age who live in low-resource, food-
insecure settings are vulnerable to vitamin A deficiency. Of par-
ticular concern are those in the latter half of pregnancy when
nutritional demands are high and circulating vitamin A concentra-
tions are low in part due to hemodilution, which complicates eval-
uation. Consequently, the risk of developing nightblindness and
other adverse health outcomes is greatest during this period (31, 32).
Vitamin A deficiency tends to cluster within countries. Com-
mon features of areas of endemic vitamin A deficiency include
poverty, a high incidence of infectious diseases, limited infrastruc-
ture, and food insecurity resulting in poor availability and acces-
sibility to vitamin A–containing foods. In such settings, a vicious
cycle often exists of vitamin A deficiency leading to increased sus-
ceptibility to and severity of infection, which, in turn, can reduce
intake and accelerate body losses of vitamin A (95).
The global response: vitamin A supplements. Global
progress has been made to reduce child deaths from vitamin A
deficiency, with estimates decreasing from 1.3 to 2.5 million
preventable deaths to;650,000 deaths annually from 1992 (96)
to 2003 (97). This trend can be explained, in part, by reduced
FIGURE 2 Vitamin A and provitamin A carote-
noids are fat-soluble. Therefore, lipid is needed for
the best absorption. After consumption, retinyl
esters are hydrolyzed by nonspecific hydrolases
and mixed with lipid and bile salts to form micelles
along with the provitamin A carotenoids. After the
micelles are absorbed into the enterocyte, provita-
min A carotenoids can be cleaved to retinol by
b-carotene 15,15#-dioxygenase. Retinol is then
esterifed to FAs and incorporated into chylomicra
along with carotenoids that were not cleaved. The
chylomicra travel through the lymph into the blood-
stream and lose some of the retinyl esters and
carotenoids to tissues while in circulation. Ulti-
mately, the remaining retinyl esters and carotenoids
are taken up by the liver as chylomicron remnants.
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fatality from measles [by ;50% (89)] and severe diarrhea and
dysentery [by ;40% (98–101)] as a result of improved vitamin
A status. Between 1986 and 1992, 5 population-based interven-
tion trials in Southeast Asia (23), South Asia (98, 102), and Africa
(103, 104) found that high-dose vitamin A supplementation
(200,000 IU retinyl palmitate every 6 mo) could reduce child
mortality among children aged 6–59 mo by 6–54%. Meta-
analyses of vitamin A supplementation trials concluded that
supplementation reduced mortality by 23% (29) and 30% (105).
These findings are in agreement with a more recent meta-analysis
that investigated 17 trials and reported a similar reduction of 24%
(106). Nonetheless, population data from India reported a modest
4% reduction and the 95% CI included 1.0 (43). Thus, the
effectiveness of vitamin A supplementation in early childhood is
well-established but may be population dependent. Further
placebo-controlled trials of vitamin A supplementation in children
between 6 and 59 mo of age are not needed, as recommended by
the WHO (38), but monitoring is important to determine when
supplementation is no longer needed.
Although the WHO continues to recommend high-dose
supplements for infants and young children aged 6–59 mo (38)
(Table 2), the most effective dose and frequency of delivery,
especially among neonates, have not been determined because of
equivocal findings. This lack of consensus is reinforced by several
conflicting reports. In 3 studies in neonates, oral supplementation
with ;50,000 IU vitamin A in oil shortly after birth was reported
to reduce mortality by 15% in Bangladesh (107), by 23% in India
(36), and by 64% in Indonesia (37). Another study showed a
beneficial impact of vitamin A in boys, but not girls, in response to
infant supplementation in Guinea-Bissau (108).
These findings indicate that reductions in infant mortality may
be population dependent. Recent large, randomized, double-blind,
placebo-controlled trials in Ghana (44) and Tanzania (45) showed
no impact on child survival. In another study in India (46), a non–
statistically significant reduction inmortality of 10%was observed
in infants followed up to 6 mo of age. In the latter findings, the
95% CI of the estimate (0–19%) included the possibility of ‘‘no
effect.’’ At the current time, the WHO does not recommend infant
dosing for a reduction in morbidity and mortality (39).
Progress in reducing maternal mortality has also been achieved
under high-risk conditions. For example, in southern Nepal,
maternal mortality rates exceeded 600/100,000 live births in 1994
(33). Once-weekly supplementation with either 7 mg vitamin A or
42 mg b-carotene reduced all-cause pregnancy-related mortality
by 40%and 49%, respectively (33). However, a trial in Bangladesh
with similar supplementation amounts failed to improve maternal
or infant survival in a population in whom vitamin A status was
marginal to normal and in whom maternal mortality was lower
than that observed in Nepal (109).
In summary, periodic vitamin A supplementation is beneficial,
especially in preschool children living in the developing world
when dietary sources of vitamin A are scarce and not commonly
consumed. However, some population groups may not respond to
supplementation, and this is likely due to the underlying adequate
vitamin A status of the intervened groups.
Current guidelines for use. As will be covered in greater detail
below, the storage of vitamin A in the liver tends to mitigate the
development of intoxication due to intakes in excess of physiologic
needs by esterifying it to FAs and storing it in stellate cells for
future use during times of low dietary intake. Thus, vitamin A can
be administered in relatively large, infrequent doses; however,
frequent vitamin A supplementation or fortification may accumu-
late in stores over time. As discussed above, this approach has shown
efficacy in the prevention of mortality but does not necessarily
increase group serum retinol concentrations (110) or result in a shift
in the distribution of serum retinol concentrations at the population
level (111). The most common delivery regimens and response times
for women and infants with vitamin A deficiency are highlighted
in Text Box 2. Table 2 lists current WHO recommendations for
vitamin A supplementation.
TABLE 3 Fortification specifications for effective
implementation1
d A regularly consumed food, produced by a few centralized factories, is required
d The fortificant must not change sensory attributes and must contain a highly
bioavailable form of the nutrient
d Fortified foods should provide $15% of the recommended daily intakes for the
target group
d Voluntary fortification of processed foods should be regulated to prevent excessive
consumption of vitamin A
d Neighboring countries should harmonize technical standards, facilitate compliance,
and minimize conflicts over global trade laws
d A practical monitoring system should be instituted
d Social marketing activities should be permanent and aimed at industry, government,
and consumers
d Food fortification might be combined with other strategies (e.g., supplementation)
to reach those not adequately covered by fortification alone
1 Summarized from reference 59.
TABLE 4 Global prevalence of serum retinol concentrations ,0.7 mmol/L and number of individuals
affected in populations of countries at risk of vitamin A deficiency, 1995–20051
WHO region
Preschool children Pregnant women
Prevalence,2 % Number affected, in millions Prevalence, % Number affected, in millions
Africa 44.4 (41.3, 47.5)3 56.4 (52.4–60.3) 13.5 (8.9, 18.2) 4.18 (2.73–5.63)
Americas 15.6 (6.6, 24.5) 8.68 (3.70–13.7) 2 (0.4, 3.6) 0.23 (0.04–0.41)
Southeast Asia 49.9 (45.1, 54.8) 91.5 (82.6–100) 17.3 (0.0, 36.2) 6.69 (0.00–14.0)
Europe 19.7 (9.7, 29.6) 5.81 (2.87–8.75) 11.6 (2.6, 20.6) 0.72 (0.16–1.29)
Eastern Mediterranean 20.4 (13.2, 27.6) 13.2 (8.54–17.9) 16.1 (9.2, 23.1) 2.42 (1.38–3.47)
Western Pacific 12.9 (12.3, 13.5) 14.3 (13.6–14.9) 21.5 (0.0, 49.2) 4.9 (1.00–11.2)
Global 33.3 (31.3, 35.4) 190 (178–202) 15.3 (7.4, 23.2) 19.1 (9.30–29.0)
1 Data are from the WHO (1). Population subgroups: preschool children (,5 y old) and pregnant women (no age range defined).
2 Excludes countries with a 2005 gross domestic product $$15,000.
3 Estimated prevalence; 95% CI in parentheses (all such values).
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The recommended dosing regimens outlined are safe, al-
though symptoms, such as headache, nausea, or vomiting and
diarrhea, indicative of acute hypervitaminosis immediately after
the dose, have been reported at a frequency of 3–7% (114).
Importantly, these short-term side effects are transient, with the
large majority (more than two-thirds) starting and disappearing
within 24 h of dosing (114). Furthermore, metabolic studies
have suggested that the recommended dosing regimen for
children at risk of vitamin A deficiency will not cause any
important risk of longer-term toxic side effects (114, 118).
High doses of vitamin A (>10,000 IU/d) should not be given
to women who could be pregnant because of the risk of
teratogenic effects in the fetus (119). There is strong evidence,
however, that a vitamin A dose of up to 10,000 IU given daily, or
a dose of up to 25,000 IU given weekly, is safe (119). Indeed,
once-weekly supplementation with ;23,000 IU vitamin A
reduced all-cause pregnancy-related mortality by 40% in a
vitamin A–deficient population (33).
At the current time, the WHO does not recommend that
pregnant or postpartum women receive vitamin A supplements
due to a lack of evidence that they improve infant and maternal
mortality rates (40, 41) or for the prevention of mother-to-child
transmission of HIV (42). However, in areas in which vitamin A
deficiency is a public health problem determined by using
biochemical and clinical indicators, supplements should be given
to prevent nightblindness (Table 2) (40).
Periodic high-dose vitamin A supplementation remains the
most widely practiced method to prevent deficiency (38). The
efficacy of high-dose vitamin A prophylaxis appears to be;90%
in preventing any stage of xerophthalmia for 6 mo in children
(89), despite a likely dosage absorption and retention of only
30–50% under conditions of morbidity and undernutrition
found in developing countries when the original supplementa-
tion studies were performed (89). Program effectiveness was
expected to be ;75% effective in preventing children from
developing xerophthalmia in high-risk populations (89). Ma-
ternal supplementation after delivery, which is usually admin-
istered within 8 wk of birth, has improved nightblindness
and low serum retinol concentrations in mothers after de-
livery (31, 32, 120) but is currently not recommended by the
WHO (41).
Intake recommendations and Tolerable Upper Intake
Levels. The 2 most widely cited sources of dietary vitamin A
intake recommendations are those of the Institute of Medicine
(IOM) in the United States (34) and the FAO/WHO (57). As
highlighted in Table 5, recommendations are presented by age
and life-stage group to reflect physiologic needs. In general, the
FAO/WHO recommended intakes are lower or similar to those
of the IOM when comparing different ages and sexes. The main
difference between these recommendations is that those by the
IOM are based on preformed vitamin A and retinol activity
equivalents (reflecting an estimate of 12 mg b-carotene or 24 mg
other provitamin A carotenoids to supply 1 mg retinol), whereas
the FAO/WHO uses retinol equivalents (reflecting an estimate of
6 mg b-carotene or 12 mg other provitamin A carotenoids to
supply 1 mg retinol).
The IOM has defined a Tolerable Upper Intake Level (UL) for
vitamin A, which is extrapolated from the lowest-observed-
adverse-effect level of intake from a small number of case reports
(34). The UL is set at the no-observed-adverse-effect level of
intake, which is derived with uncertainty factors. The UL for
vitamin A is based only on preformed retinol and is 600 mg/d for
infants and children aged <3 y and increases to 3000 mg/d
for adults (Table 5). The WHO recommends that women who
are or might become pregnant limit their total daily vitamin A
intake to a maximum of 3000 mg retinol equivalents/d (10,000
IU) or weekly intakes of <7500 mg to minimize the risk of fetal
toxicity (40). The lowest reported daily supplement associated
with liver cirrhosis is 7500 mg/d taken for 6 y (121, 122).
Implications of vitamin A toxicity have been reviewed (51, 121).
Biology of Vitamin A
To support efforts to 1) discover, develop, and implement new
biomarkers and 2) most effectively utilize and interpret existing
ones, it is essential to understand the metabolism and roles of
vitamin A within biological systems. The following sections
cover the role of vitamin A to provide context to the subsequent
discussions on specific existing and new biomarkers.
Functional roles of vitamin A. Vitamin A is required for the
regulation of numerous key biological processes including roles
in the following:
· vision,·maintenance of epithelial surfaces,· immune competence,· reproduction, and· embryonic growth and development.
Retinol is the precursor for $2 essential biologically active
molecules: all-trans retinoic acid as the ligand of nuclear
Text Box 2 Recommended Dosing Regimens to Treat Vitamin A Deficiency
d In children with clear or suspected xerophthalmia, vitamin A should be administered orally in age-specific large doses
according to WHO treatment guidelines, followed by an additional dose the next day, and 2–4 wk later (112).
d Xerophthalmia cases should be treated with age-specific dosages on days 1, 2, and 14; measles cases on days 1 and 2; and
severe undernutrition cases (i.e., kwashiorkor or weight-for-height, –3 z scores below the international referent median) on
day 1 (113, 114).
d For women of reproductive age (13–49 y) with active corneal lesions, 200,000 IU should be given on days 1, 2, and 14.
d Women with milder eye signs (nightblindness or Bitots spots) should be treated with 10,000 IU/d or 25,000 IU/wk for
.3 mo (113–115).
Expected responses
d Nightblindness responds within hours to days of high-potency vitamin A treatment, leading to a return to normal scotopic
(nighttime) vision (115, 116), although full recovery of visual function may take weeks.
d Bitots spots in preschool children generally respond rapidly to high-potency vitamin A treatment within 2–5 d, becoming
smaller in size and disappearing within 2–3 wk (116, 117).
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receptors, such as RARs (71, 123), and 11-cis-retinal required in
the visual cycle (124, 125). The details of the vitamin A pathways
involved in these 2 functions are shown in Figure 3. The steps
involved in vitamin As role in vision and nucleic receptors are
described in Text Box 3.
Vitamin A absorption. Figure 2 presents the current under-
standing of the events and components associated with absorption
of preformed vitamin A and provitamin A carotenoids. Most
dietary preformed vitamin A is composed of long-chain FA esters
of retinol, which must be hydrolyzed in the proximal small
intestinal lumen before absorption by the intestinal epithelial cells
(127). Some fortificants and supplements are in the acetate form,
which can sometimes be found in the circulation, suggesting that
retinyl acetate, which is not found endogenously, can be absorbed
intact without previous hydrolysis in the gut (128).
After hydrolysis in the gut and absorption by the mucosal cells,
retinol is re-esterified with long-chain, mainly saturated, FAs, such
as palmitate, by the enzyme lecithin:retinol acyltransferase (LRAT)
(127). The resulting retinyl esters are incorporated with other
neutral lipid esters into chylomicra and secreted via the lymph duct
into the general circulation. Much of the chylomicron TG is hy-
drolyzed by lipoprotein lipase in extrahepatic tissues. Some retinyl
esters are released to extrahepatic tissues from the chylomicra (129),
particularly in the lung and spleen (130), whereas the majority is
deposited into the liver (129, 130).
Vitamin A in the liver. The key components of vitamin A
metabolism in the liver are highlighted in Figure 4. The majority
of the chylomicron remnants, containingmost of the newly absorbed
retinyl esters, are taken up by the liver where the retinyl esters are
hydrolyzed to retinol, which can then be bound to retinol-binding
protein (RBP) or re-esterified to FAs by LRAT (127). Under
conditions of adequate vitamin A nutriture, the liver is the main site
of vitamin A storage, with >95% of the total retinol esterified
to FAs, predominantly retinyl palmitate and stearate in vitamin
A–adequate humans. Small amounts of retinyl esters can be stored
in the intestine and kidney (130, 131). Adipose tissue likely re-
presents a large underappreciated storage site (132), especially in
vitamin A–adequate individuals. Before mobilization from the liver,
the retinyl esters are hydrolyzed and free retinol is complexed to
RBP for secretion from the liver into blood (127). The retinol:RBP
complex is further stabilized by binding to transthyretin in plasma
(133).
In 2007, stimulated by retinoic acid 6 receptor (STRA6) was
identified as a cell surface receptor for RBP to release retinol (134).
STRA6, however, is not expressed in all cell types, and studies in
Stra6-deficient mice suggest that there are other pathways that
facilitate retinol uptake into cells (135). These pathways, which
include distribution from within chylomicra or other lipoproteins,
are likely those that distribute a-retinol, which does not bind
to RBP (130, 136), and retinol in RBP-knockout mice tissues
(137, 138). a-Retinol is formed from the symmetric cleavage of
a-carotene and supports growth in vitamin A–deficient rats (139).
Vitamin A homeostasis and storage. Total body vitamin A
stores regulate vitamin A homeostasis (140). Vitamin A status also
indirectly regulates bioconversion of provitamin A carotenoids to
retinol (79, 141, 142). Bioconversion in the intestine is regulated
through a diet-responsive regulatory network (74). The expression
TABLE 5 Recommendations for vitamin A intake by age or population group by the Institute of Medicine (34) and the FAO (57)1
Life-stage group
US Institute of Medicine FAO
EAR, mg RAEs/d AI or RDA, mg RAEs/d UL,2 mg REs/d Mean requirement, mg REs/d Recommended safe intake, mg REs/d
Infants
0–6 mo — 400 600 180 375
7–12 mo — 500 600 190 400
Children
1–3 y 210 300 600 200 400
4–6 y — — — 200 450
4–8 y 275 400 900
7–9 y — — — 250 500
9–13 y — — — — —
Male 445 600 1700 — —
Female 420 600 1700 — —
Adolescents aged 10–18 y 330–400 600
Adults
Females
14–18 y 485 700 2800 — —
$19 y 500 700 3000 270–300 500–600
Males
14–18 y 630 900 2800 300 600
$19 y 625 900 3000 300 600
Pregnancy
14–18 y 530 750 2800 370 800
19–50 y 550 770 3000 370 800
Lactation
14–18 y 885 1200 2800 450 850
19–50 y 900 1300 3000 450 850
1 RAEs are based on preformed retinol and a bioconversion factor of 12 mg b-carotene to 1 mg retinol (34), and REs are based on preformed retinol and a bioconversion factor of 6 mg
b-carotene to 1 mg retinol (57). AI, Adequate Intake; EAR, Estimated Average Requirement; RAE, retinol activity equivalent; RE, retinol equivalent; UL, Tolerable Upper Intake Level.
2 The UL is based on preformed retinol alone.
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of intestine-specific homeobox transcription factor (ISX) is activated
by retinoic acid via RARs that bind to a specific retinoic acid re-
sponse element within the ISX promoter. Once activated, ISX
represses intestinal scavenger receptor class B type 1 andBCO1expres-
sion, indicating that intestinal provitamin A uptake and vitamin A
production are under negative feedback control via induction of ISX
expression (143).
It is currently not known to what extent provitamin A
carotenoid absorption and/or bioconversion are affected by liver
vitamin A reserves (74). However, Zambian children with
hypervitaminosis A, diagnosed by using stable isotope dilution
(85), also had high serum carotenoid concentrations (144) and
many of them experienced hypercarotenodermia during mango
season, a period of high carotenoid intake (145). This would
indicate that even at mean estimated liver vitamin A concentra-
tions, at or above the current cutoff for hypervitaminosis A
(>1 mmol/g liver), carotenoid absorption is not severely impaired.
Studies that described the influence of vitamin A status on
utilization and provitamin A carotenoid bioconversion come
predominantly from animal models. In rats with low to marginal
vitamin A status, vitamin A utilization decreases to maintain
balance (140). In a gerbil model, bioconversion of provitamin A
carotenoids slows at a liver reserve concentration of 0.4 mmol/g
(79, 142), suggesting that between 0.1 and 0.4 mmol/g the body is
in balance (53). Above 0.4 mmol/g liver, decreased provitamin A
carotenoid bioconversion likely causes serum carotenoid concen-
trations to increase in humanswho consume high amounts of plant-
source foods, as observed in Zambian children (85, 144, 145).
Vitamin A interactions with other nutrients. Nutrient-nutrient
interactions have been observed between preformed vitamin
A/provitamin A carotenoids and both macronutrients and other
micronutrients. Text Box 4 contains a summary of some human
studies that investigated interactions with various micronutrients.
Obviously, as a ‘‘fat-soluble’’ vitamin, dietary fat has long been
understood to affect absorption of both preformed vitamin A and
provitamin A carotenoids (34). Studies of the impact of fat on
provitamin A carotenoid absorption and metabolism are illustra-
tive of this relation and include the following observations:
·Numerous studies have shown that intestinal absorption of
carotenoids can be increased by dietary fat intake through
increased incorporation into mixed micelles (74).
· In animals fed graded amounts of fat, the bioefficacy of
sweet potato b-carotene was enhanced with the highest fat
amount (155).
·Only 3–5 g fat/meal ensures efficient absorption ofb-carotene
in humans (156, 157).
·Higher bioconversion of provitamin A carotenoids has been
observed in animals fed a diet rich in MUFAs and n–3
PUFAs compared with an n–6 PUFA–rich diet (74).
FIGURE 3 Schematic diagram showing the met-
abolic pathways of vitamin A metabolism. CRBP,
cellular retinol-binding protein; CYP26, cytochrome
P450 26; LRAT, lecithin:retinol acyltransferase;
RALDH, retinaldehyde dehydrogenase; RDH, ret-
inol dehydrogenase; retSDR1, short-chain retinol
dehydrogenase/reductase; RPE65, retinal pigment
epithelium-specific protein 65kDa; SDR, short-chain
dehydrogenase/reductases. Adapted from refer-
ence 124 with permission.
Text Box 3 Critical Steps in the Functions of Vitamin A
Vision [reviewed in (125)]
d 11-cis Retinal binds to opsin to form rhodopsin, which can absorb light within the visible spectrum.
d When 11-cis retinal absorbs a photon, it isomerizes to all-trans retinal through several intermediate species and is rapidly
released from opsin.
d The isomerization of 11-cis retinal is the initial step in vision. An excited intermediate of rhodopsin greatly amplifies light-
induced hyperpolarization of the rod membrane, resulting in generation of the nerve impulses for vision.
Nuclear receptors/gene regulation
d All-trans retinoic acid is the most biologically relevant metabolite of vitamin A.
d Retinoic acid binds and activates several nuclear receptors, i.e., RARs, retinoid X receptor, and PPARs (126).
d Upon ligand binding, RAR dimerizes with a retinoid X receptor to form a heterodimer, which then initiates gene
transcription by binding to the retinoic acid response element in the promoter region of .500 target genes (71).
1824S Supplement
D
ow
nloaded from
 https://academ
ic.oup.com
/jn/article-abstract/146/9/1816S/4584876 by guest on 05 August 2020
Another macronutrient shown to influence vitamin A me-
tabolism is protein. Conversion efficiency is influenced by an
Adequate Intake of high-quality protein, which is crucial for
BCO1 protein biosynthesis (74).
Implications for public health. Among the uses of biomarkers
of nutrients, biological function is critical both in terms of
understanding the role of nutrients within biological systems but
also for identifying relevant clinical or biological outcomes of a
given nutrient status. Vitamin A serves a number of functional
roles in human biology, and a clearer understanding of those
roles will not only improve our appreciation of vitamin As role
in health and disease but will also help identify current and new
biomarkers that might be used clinically and in population
surveys. Some groups of individuals are more at risk than others
of vitamin A deficiency and excess and these are described in
Text Box 5. Ramifications of deficiency and excess are shown
in Figure 5.
One of vitamin As best characterized functions is its role in
the immune system. Text Box 6 highlights the known regulatory
roles.
Vitamin A may play a role in numerous communicable and
noncommunicable diseases of public health concern. Some of
these are highlighted in Text Box 7.
Currently Available Vitamin A
Biomarkers: Overview
The currently available biomarkers of vitamin A considered by the
Biomarkers of Nutrition for Development (BOND) initiative are
summarized in Table 6 (185), which includes a concise overview of
the biomarker and the utility for different purposes/user groups
(i.e., research, clinical, program policy). To provide some additional
clarity, Table 7 includes a rating system for the usefulness of each
indicator for a specific use, including the advantages and disad-
vantages, and a brief coverage of analytical considerations, which
are further covered in Table 8.
Biomarker-Specific Issues
Liver reserves of vitamin A are considered the gold standard for
vitamin A assessment. The previous cutoff of 0.07 mmol/g liver
FIGURE 4 After absorption, retinyl esters and carotenoids can be released from chylomicra into tissues. Malformed chylomicra can be
scavenged by the spleen. However, the bulk of retinyl esters and carotenoids make their way to the liver in chylomicron remnants. In the liver,
the retinyl esters can be hydrolyzed by retinyl ester hydrolase. Retinol can then be either complexed with RBP and released into the plasma or re-
esterifed by LRAT for long-term storage. The carotenoids can be cleaved to retinol (although not a major pathway in the liver), stored, or packaged
into VLDLs and released into the circulation. Retinol uptake from RBP by cells can be facilitated by STRA6. BCO2, b-carotene 9,10-oxygenase;
LPL, lipoprotein lipase; LRAT, lecithin:retinol acyltransferase; RBP, retinol-binding protein; RE, retinyl esters; REH, retinyl ester hydrolase; ROH,
retinol; ROOH, retinoic acid; STRA6, stimulated by retinoic acid 6 receptor; aC, a-carotene; bC, b-carotene.
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was based on an estimated protection from clinical signs for
4 mo in average-weight individuals (34). In 2010, commonly
used biomarkers were plotted against liver reserves of vitamin A
to define the range of liver reserves associated with specific
biomarkers (186) (Figure 6). Research in animals suggests that
the cutoff for vitamin A deficiency should be set at <0.1 mmol/g
liver, as follows:
· Data obtained in rats showed downregulation of LRAT,
which is the enzyme responsible for retinol esterification
leading to storage (187).
· Studies in rats and piglets showed that apo-RBP begins to
accumulate below this liver concentration (186, 188),
eliciting a response with the MRDR test (186).
· In rats, biliary excretion of metabolites of vitamin A signif-
icantly increased at liver reserves >0.1 mmol/g liver (189).
The evidence for setting the cutoff for hypervitaminosis A is
limited. Nonetheless, >1 mmol/g is likely associated with hyper-
vitaminosis A for most individuals (145). In 2010, the term
subtoxic was used to define this cutoff; however, the consensus
of the BOND Vitamin A Expert Panel is that until more data
exist with regard to adverse effects at either higher or lower liver
concentrations, the terms hypervitaminosis and toxic are more
appropriately used for liver concentrations >1 mmol/g liver and
10 mmol/g liver with 1 significant digit, respectively (Figure 6).
In the past, a more conservative cutoff of 0.7–1 mmol/g was
considered excessive (190). Considering the widespread use of
fortified foods in both developed and developing countries,
future research needs to determine if there are deleterious effects
at liver retinol concentrations <1 mmol/g.
After briefly discussing dietary assessment of vitamin A, bio-
markers that are in use will be discussed under 2 main sub-
headings: ‘‘Physiologic (functional) measures of vitamin A
status’’ and ‘‘Biochemical indicators of vitamin A status.’’ The
emphasis of the following sections is primarily on biomarkers
used to assess vitamin A dietary insufficiency, although markers to
assess excessive vitamin A status are also briefly reviewed.
Dietary assessment
Although currently no sensitive or specific biomarkers of short-
or long-term exposure exist, dietary assessment is an essential
component of the vitamin A assessment toolkit. Dietary assess-
ment methods include the following: dietary records, 24-h
dietary recall, FFQs, brief dietary assessment instruments, and
diet history. The dietary assessment methodologies and the
issues around them have been extensively reviewed (191).
Researchers need to be aware of which foods in the country
being evaluated are fortified, especially with preformed vitamin
A. An awareness of seasonality of different fruit and vegetable
sources of provitamin A carotenoids is also important when deter-
mining which times of the year to complete dietary assessments.
Supplement coverage or individual usage can also support dietary
record data.
Vitamin A deficiency occurs when dietary intake is not
enough to meet demands (Figure 5). The body can downregulate
bioconversion of provitamin A carotenoids, and therefore high
intakes of fruit and vegetables will usually not cause concern for
hypervitaminosis A. However, if the dietary intake of preformed
vitamin A becomes high through foods, such as liver, fortified
foods, or supplements, the body will store the excess in the liver
and the concentration will continue to increase (142).
Physiologic (functional) measures of vitamin A status
As highlighted throughout this report, vitamin A plays a number
of key roles in human biology.Many tools exist to assess particular
biological functions. However, it is essential to recognize that
many functional tests are actually ‘‘bioindicators,’’ reflecting per-
turbations in specific biological systems rather than sensitive and
specific biomarkers of nutrient exposure, status, or effect (192). In
the context of evaluating the functional impact of vitamin A, a num-
ber of measures exist that, in combination with specific biomarkers,
can be used to assess functional implications of vitamin A status.
The following sections highlight the most commonly used of these
bioindicators.
Text Box 4 Examples of Vitamin A–Micronutrient Interactions in Humans
Iodine
d Vitamin A status modulates thyroid gland and hormone metabolism and the production of thyrotropin by the pituitary
gland. Vitamin A deficiency is associated with a decrease in vitamin A–mediated suppression of the pituitary thyroid-
stimulating hormone b (TSHB) gene and an associated increase in thyroid-stimulating hormone stimulation and goiter
(146).
d In Moroccan children with concurrent deficiencies of vitamin A and iodine, those who received both iodized salt and
vitamin A supplementation had enhanced efficacy in iodine deficiency disorder outcomes (147).
d Hypothyroidism does not reduce the efficacy of high oral doses of vitamin A, vitamin A deficiency does not reduce the
efficacy of dietary iodine to correct iodine deficiency disorders, and high-dose vitamin A supplementation may reduce
thyroid hyperstimulation and the risk of goiter (146).
Iron
d Administering vitamin A enhanced hemoglobin response to iron supplementation during adolescence and pregnancy (148–
150).
d In a subgroup of pregnant Indonesian women (148), vitamin A status when assessed by the modified-relative-dose-response
(MRDR) test, improved more markedly with the combination of vitamin A and iron than with either nutrient alone (151).
d In human infants, iron supplementation lowered plasma retinol concentrations but led to greater liver storage of vitamin A
(152).
d Ethiopian children given a single high-dose vitamin A supplement had improved hemoglobin concentrations (153).
Zinc
d Zinc and vitamin A work in synergy for many functions in the body. Therefore, poor zinc status may negatively affect
vitamin A status biomarkers.
d In a human study, zinc was suggested as a cofactor for the action of BCO1 (154), but the exact role of zinc has not been
elucidated.
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Dark adaptation. Dark adaptation, which is the ability to see
under dim lighting conditions with time, was first described in
the mid-19th century (193) and first measured under standard-
ized conditions at the beginning of the 20th century (194). Once
the importance of vitamin Awas recognized for the visual cycle,
it was only a matter of time before dark adaptation testing
(vision at low light intensity) began to be used for the detection
of vitamin A deficiency. In individuals who do not have adequate
vitamin A nutrition, the ability of the rod cells to adapt in the
dark, and for pupils to properly meter light in and out of the
eye, may be impaired. This may result in a condition called
nightblindness.
The retina consists of 2 types of photoreceptors: rods and
cones. The rods are located in the peripheral retina and the cones
are located in the central macula region of the retina. The rods
enable vague, colorless vision at low light-intensity levels (e.g.,
moonlight), whereas the cones enable clear vision with color at
higher light intensities. This important rod function is linked to
the size of the pupil, which opens in the dark to allow light to
reach the back of the eye and becomes smaller in bright light.
When an individual first moves from a brightly lit space into
relative darkness, he or she initially can see practically nothing.
However, as the retina gradually shifts from cone to rod vision,
the individual can begin to see dimly lit objects take form. The
ability to accurately measure the speed at which this adaptation
takes place and the absolute lowest level of light intensity while
still being able to see allowed for the physiologic demonstration
of the importance of vitamin A in the dark adaptation process
and for using dark adaptation to detect vitamin A deficiency.
Eventually, dark adaptation testing under highly controlled
experimental conditions was used to help define the dietary
requirements for vitamin A and the efficiency of the conversion
of b-carotene to vitamin A (195). Initially, the time to perform
dark adaptation testing was lengthy, and the equipment for
classical dark adaptation testing was cumbersome. However,
newer equipment and techniques for measuring dark adaptation
in field settings are now available, and some of these are
described below.
Classical testing. In classical dark adaptation testing, a
cumbersome and expensive adaptometer is used, which consists
of 3 main elements: a globe that is open on 1 side, a chin rest,
and a light-intensity adjustment knob, which is operated by a
trained technician. The test subject must first have his or her eye
dilated, and then is light-adapted at a bright standard intensity
for ;10 min. In a darkened room, the seated subject rests his or
her chin on the chin rest and fixates on a red light that is 15
above the center of a test (white) light (both lights are located at
the back of the open globe). The test white light consist of flashes
lasting 1 s, the intensity of which can be increased or decreased
by the technician depending on the subjects responses.When the
subject says that he or she can see the test flashes, the technician
can lower the light intensity until the subject can no longer detect
FIGURE 5 Dietary intake of vi-
tamin A is in 2 major forms:
preformed vitamin A from animal-
source foods, supplements, and
fortificants and provitamin A carot-
enoids from plant foods and some
supplements. The body can regu-
late how much vitamin A is formed
from provitamin A carotenoids, but
preformed vitamin A is highly bio-
available. Thus, as dietary intake
increases beyond requirements so
do liver retinol reserves. The man-
ifestations of vitamin A deficiency
are severe, from blindness to death.
The manifestations of vitamin A
excess are not entirely known, but
when severe, can also lead to ill
health and death. RBP, retinol-bind-
ing protein.
Text Box 5 Risks Groups for Deficiency and Excess
Risk of vitamin A deficiency
d Preterm infants, who have low stores as a result of interrupted accretion during gestation
d Infants and children, particularly those whose mothers are vitamin A deficient during lactation
d People with malabsorption conditions including biliary atresia and cystic fibrosis
d People living in food-insecure environments without access to fortified foods
d Individuals suffering from alcoholism
Risk of vitamin A excess
d People with access to multiple fortified foods or who consume liver on a regular basis
d Chronic preformed vitamin A supplement users
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the flashes. Then, the technician can slowly increase the light
level until the subject says that he or she can now see the flashing
light. A tracking method is used such that the light intensity
detected by the subject [measured in log candela (log cd)/m2] is
plotted against time (Figure 7). The dark adaptation curve
follows a characteristic pattern: there is an initial decrease in
the luminance threshold due to cone adaptation, followed by a
short plateau. Then, at the rod-cone break, rod vision kicks
in and a slower, second luminance threshold descent begins,
becoming stabilized in ;35–40 min. A learning effect can
occur, so each subject should be given a trial run before a true
dark adaptation test is begun. In one study, the final dark-
adapted threshold among healthy adult subjects was 25.0
(60.3 log cd/m2).
In vitamin A deficiency, the subjects rod-cone break takes a
longer time to achieve and the final dark-adapted threshold is
elevated by 1–2 log cd/m2. Classical dark adaptation will be
abnormal in subclinical vitamin A deficiency before symptoms
of nightblindness occur (196). Classical dark adaptation is a
direct test of a vitamin A–dependent biological system; thus, no
surrogate biomarkers are needed. However, the precise delicate
equipment can only be used in controlled clinical or experimen-
tal conditions. Due to the high degree of attention that is required
on the part of the test subject, children should not be tested with
this technique. Moreover, there are a number of confounding
factors, which, if present, might yield an abnormal final threshold
result that is unrelated to vitamin A deficiency. Among the
confounders are eye diseases and zinc (197) or protein (198)
deficiency. Subjects to be tested must be free of these deficiencies,
because these nutrients are needed for RBP synthesis and for
transport of vitamin A to the eye. Furthermore, aging can affect
dark adaptation in an inconsistent manner due to varying degrees
of age-related cataracts, retinal degeneration, and, in some older
people, the inability to concentrate (199, 200).
Rapid dark adaptation testing. Rapid dark adaptation
testing is dependent on the shift from cone to rod vision when
dark adaptation is occurring. When one shifts to rod vision
under dim-light settings, a shift in wavelength sensitivity of the
retina takes place (Purkinje phenomena), such that blue appears
brighter than red as the rods become activated (201). The rod-
cone break (described above and in Figure 7) normally occurs
in <10 min in the dark; therefore, the ability to see blue as
brighter than red occurs well within this time interval.
The equipment needed for rapid dark adaptation is much
simpler than that needed for classical dark adaptation: a dark
room; a very dim light source (7.5 watts filtered to allow 1%
transmission); a dark, nonreflective work surface; a stop watch;
a bright light-adapting source; and colored chips or discs (6 each
of a blue-dominant wavelength of 475 nm, a red-dominant
wavelength of 605 nm, and white). After an initial period of
bright light adaptation of 1 min, the subject sits in darkness in
front of the nonreflective table surface on which the colored
discs have been placed. He or she can quickly separate the white
chips away from the rest, but the separation of the blue chips
from the red takes longer. If a mistake is made, a trained
technician returns the disc to the work surface until the subject
has accurately separated 100% of the blue from the red discs. At
this point, the time it took for the subject to complete the task is
noted and the test is over. The rapid test time in control subjects
aged 20–39 y was mean 6 SD 3.03 6 1.00 min and in control
subjects aged 40–60 y was 4.41 6 0.83 min (202). The colored
discs have been used with children $4 y of age (203).
The advantages of this test are as follows: 1) it can be
performed under most field conditions, 2) it requires only simple
and inexpensive equipment, 3) it is relatively fast to conduct, and
4) it can be performed in children. The disadvantages of this test
are that it 1) has only been performed in a relatively small
number of subjects and is in need of further validation, 2) still
requires a trained technician and a totally darkened room, and
3) has the same confounders as classical dark adaptation.
Electroretinography. The use of electroretinography (or
variants thereof) is even more restricted than for classical dark
adaptation due to the fact that the test is invasive and requires
not only eye dilation but also direct eye contact with a measuring
electrode (204). Thus, this test is only used in highly structured
clinical or research settings to measure the bioelectrical response
of the retina to a flash of light. There are 2 basic components
of the electroretinogram: a negative ‘‘a’’ wave, followed by a
positive ‘‘b’’ wave, the absolute heights of which are measured in
microvolts (Figure 8). Latencies of the ‘‘a’’ and ‘‘b’’ waves can
also be measured (i.e., the time from the light flash to the peak
amplitudes of the ‘‘a’’ or ‘‘b’’ waves). In addition to the ‘‘a’’ and
‘‘b’’ wave amplitudes and latencies, the electroretinogram can be
used to evaluate dark adaptation time (i.e., the time for recovery
from a bright light exposure of the electroretinogram to amaximal
electroretinographic dark-adapted response). The maximal elec-
troretinogram response reflects the number of photoreceptors,
whereas the dark adaptation recovery time reflects the ability
of the photoreceptors to regenerate rhodopsin after a bleaching,
bright light exposure.
This technique has not been used extensively to evaluate
vitamin A deficiency. The test is not appropriate for field settings
or for use in young children, except under strict medical supervi-
sion. The test has the same disadvantages and confounders as
classical dark adaptation and in addition has the disadvantage of
being invasive. Its advantage is that the test is wholly objective.
Text Box 6 Regulatory Roles of Vitamin A in Immune Function
d The regulatory roles of vitamin A in mammals include the maintenance of epithelial cell differentiation and immune
competence (95, 158).
d Vitamin A supports innate immune function by supporting regeneration of mucosal barriers damaged by infection in
children and by enhancing the function of neutrophils, macrophages, and NK cells, as described primarily in rodents (95).
d Vitamin A is required for adaptive immunity and plays a role in the development of T-helper (Th), T-regulatory, and B cells,
but more in vivo work is needed (95).
d All-trans retinoic acid is a potent regulator of gene expression, and it controls leukocyte homing and T-regulatory function
(reviewed in 159). Its production by cells of the immune system is regulated during an immune response in a manner that is
still being elucidated (160).
d In human T lymphocytes, all-trans retinoic acid inhibited the production of cytokines that favor the generation of Th1-type
T cells and enhanced the production of cytokines favoring the Th2-type T cells (161).
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Pupillary threshold testing. Pupillary threshold testing
reflects the dark-adapted pupillary reflex (pupillary restriction
on light exposure) at low-intensity light exposures that are near
the visual threshold (205). This test has the advantage over
classical and rapid dark adaptation in that it is entirely objective.
Moreover, the test can be carried out in children as young as 3 y
old and under field conditions (206). Although the test has not
been widely used to date, it may provide an objective, nonin-
vasive, rapid, portable, physiologic field test for the assessment
of vitamin A deficiency.
The absolute pupillary threshold is known to be higher than
the visual threshold. Special pairs of goggles were invented to
measure pupillary response to light stimuli (207). One of the
earlier goggle versions required a dark room, a camera with
flash, a goggle apparatus to fit over 1 eye in order to illuminate
the entire retina of that eye, and an oblique red-light–emitting
diode source. After exposure of both eyes to the camera flash, the
test subject is dark-adapted for 10 min. The illuminating goggle is
then placed over the subjects left eye, while the pupil of the right
eye is observed (while under red illumination from a side-mounted
Text Box 7 Functional Roles of Vitamin A: Implications for Public Health
Anemia
d Vitamin A deficiency negatively affects hemoglobin concentrations. Supplementing women with vitamin A and iron
enhanced hemoglobin concentrations more than either nutrient alone (148).
Cancer
dMeta-analyses of human studies have shown an inverse relation between dietary amounts of vitamin A and various cancers,
for example, bladder (162), breast (163), cervical (164), and gastric (165).
d Synthetic retinoids and some naturally occurring retinoids (e.g., all-trans retinoic acid, 9-cis retinoic acid, 13-cis retinoic
acid) have been used in clinical studies (reviewed in 166).
d Certain retinoids inhibit the growth of various tumors (e.g., lung, gastrointestinal, breast) and may have chemopreventive
and/or chemotherapeutic properties (167, 168).
d All-trans retinoic acid is used as a chemotherapeutic agent to treat acute promyelocytic leukemia, and in the vast majority of
these patients this treatment leads to a complete remission (169).
Diabetes
d Type 1 diabetes has been associated with lower concentrations of serum retinol and its carrier proteins (RBP and
transthyretin) in patients (170, 171).
d Type 2 diabetes has a less-clear relation with serum retinol and carrier proteins, with some studies showing no change and
others showing reductions in type 2 diabetes (172).
dVitamin A deficiency and excess have varying and discordant effects on macronutrient metabolism in various tissues and cell
types (173–175).
dVitamin A is involved in pancreatic development and function: deficiency caused reduced b cell mass in fetal islets (173, 174)
and reduced glucagon and insulin secretion from pancreatic a and b cells, respectively (173–175).
d RBP secreted by adipose tissue has been implicated as a link between obesity and insulin resistance by interrupting insulin
signaling in muscle and increasing hepatic glucose output (176).
d In human macrophages, RBP may cause insulin resistance by contributing to adipocyte inflammation through
proinflammatory cytokine activation, and the mechanism is retinol- and STRA6-independent (177).
d The public health link of vitamin A status to diabetes needs further investigation.
Energy metabolism and obesity
d Evidence in animals exists for a role of vitamin A in maintaining energy metabolism; however, more research is needed.
d Retinoic acid exerts its broad range of biological effects in large part by controlling gene expression. Early in adipogenesis,
retinoic acid blocks differentiation, whereas after 48 h of differentiation, it promotes fat cell formation (178).
dMice lacking retinaldehyde dehydrogenase 1 (Raldh1) resisted diet-induced obesity and insulin resistance. Administration of
retinal or an Raldh1 inhibitor to obesity-susceptible mice reduced fat accumulation and increased insulin sensitivity (178).
d In mice with active protein kinase C, retinol supplementation showed that retinol is a metabolic cofactor involved in the
regulation of mitochondrial fuel utilization (179).
HIV and pregnancy
d Currently, no conclusive evidence of vitamin A supplementation on vertical HIV transmission exists; therefore, the WHO
does not recommend supplementation in HIV-positive pregnant women to reduce the risk of mother-to-child transmission
(40, 42).
d Cochrane reviews indicated that vitamin A alone (180) and micronutrient supplementation (181) should not be used as a
substitute for recommended antiretroviral medication.
d In infants with mannose-binding lectin-2 variants, vitamin A supplementation to mothers at delivery was associated with a
decreased risk of HIV transmission (182).
d Future work is needed on the effect of vitamin A supplementation on HIV transmission from mother to child that accounts
for the potential effect of an innate immune deficiency.
Measles
d On the basis of a randomized, placebo-controlled clinical trial in children with measles, along with other clinical research,
the WHO recommends that age-appropriate doses of vitamin A be given twice 24 h apart to infants and children with
measles in populations in whom vitamin A deficiency may be present to decrease the risk of death from measles (183).
d Prevention of vitamin A deficiency by using periodic, high-dose supplements in communities in which vitamin A deficiency is
a public health problem decreases the risk of developing measles in children 6–59 mo of age (184).
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light) by a trained technician. The brightness of the light stimulus
delivered by the goggle is then increased at 10-s intervals (range:
24.16 to 20.575 log cd/m2], while the right eye is observed for a
clearly visible restrictive response. A version of this apparatus has
been used in nightblind Nepalese women to evaluate various
vitamin A interventions (208). The newer versions of these goggles
do not require a dark room, but measurements are challenging for
children under the age of 5 y (207).
A pupillary threshold of < 20.575 log cd/m2 is presently
considered normal for children aged 3–5 y, although more
thorough testing is needed before arriving upon validated normal
values. The same confounders as for classical dark adaptation are
expected to be operative here as well.
Conjunctival impression cytology. In the mid-1980s, it was
recognized that the conjunctiva of the eye could be sampled and
the cells stained to determine abnormalities (209). This method
was termed conjunctival impression cytology and abnormality
was defined by the absence of goblet cells and hyperplasia of
epithelial cells. Although the method compared well with
positive MRDR tests in Indonesian children (210), it did not
work well in children in Africa due to arid conditions and it has
not been further refined (211, 212).
Biochemical indicators of vitamin A status
Serum retinol concentrations.
Assessing vitamin A deficiency in prevalence surveys
at the population level. Serum retinol concentration measure-
ments by HPLC are a common method used to assess vitamin A
status of populations (111). The current cutoff used to define a
severe public health problem for vitamin A deficiency is when
20% of children aged 6–71 mo have a serum retinol concentration
<0.7 mmol/L (213). Although currently recommended for use by
the WHO, serum retinol concentrations should not be used alone
to define the degree of public health significance but should be
used in conjunction with another biological indicator or when$4
of the following risk factors are found in the population being
evaluated (213):
· infant mortality rate >75 of 1000 live births and under-5-y
mortality rate of >100 of 1000 live births;
· full immunization coverage in <50% of children at 12–
23 mo of age;
· <50% prevalence of breastfeeding in 6-mo-old infants;·median dietary intakes <50% of recommended safe levels of
intake among 75% of children 1–6 y of age;
· 2-wk period prevalence of diarrhea of $20%;·measles case fatality rate of $1%;· no formal schooling for $50% of women 15–44 y of age;
and
· <50% of households with a safe water source (e.g., boiled,
treated, filtered, properly stored).
Serum retinol and RBP tend to be lower in infants and young
children than in adults, even in vitamin A–adequate populations.
Therefore, the same cutoff cannot be used for infants <6 mo of
age (214). However, the relative concentration to define vitamin
A deficiency in infants has not been determined and is a research
question that needs to be addressed. Serum retinol concentration
tends to increase through middle-age in the US population
(particularly in men but also in women >60 y of age) and may
represent a continuing, although less pronounced, association of
liver vitamin A stores (215).
RBP concentrations do not vary by sex, generally speaking,
and the lower serum retinol concentrations in women than in
men in middle-age may be due to differences in liver stores or to
the higher prevalence of inflammation in women (215). The
cutoff used for deficiency in adults varies, and some researchers
choose to use 0.7 mmol/L whereas others suggest 1.05 mmol/L
TABLE 6 Summary of biomarkers for vitamin A status from the BOND initiative1
Biomarkers Type Use Utility
Serum RBP Status Population Not released from the liver when retinol is limiting. Used as a proxy for serum retinol in identification
of vitamin A deficiency.
Serum/plasma retinol Status Population Most commonly used biomarker. Correlates with the prevalence and severity of xerophthalmia and
may change in response to interventions.
Dried blood spot retinol Status Population Surrogate measure of serum retinol. Correlates with serum retinol measured by HPLC.
Relative dose response Status Population, individual Based on hepatic accumulation of RBP during vitamin A depletion. Requires blood sample before and
after an oral retinyl ester dose.
Modified relative
dose response
Status Population, individual More responsive than serum retinol. Qualitatively identifies low or adequate liver vitamin A reserves.
Retinol isotope dilution Status, marker
of excess
Population Although technically challenging, it is the most sensitive test to measure vitamin A status and
intervention impact on vitamin A reserves. Minimally invasive and accurate.
Breast-milk retinol Status, exposure Population Good indicator of vitamin A status in areas where breastfeeding is common until$6 mo of age. Milk
retinol varies with milk fat; measurement of milk fat is recommended.
Retinyl esters Status, marker
of excess
Population, individual Validated qualitative measure of hypervitaminosis A. May be confounded by liver disease at the
individual level.
Dark adaptation Function Population (small scale),
individual
Dark-adapted final threshold is inversely and sensitively correlated with serum vitamin A
concentrations in the low-to-deficient ranges.
Electroretinography Function Population, individual Measures the bioelectrical response of the retina to a flash of light. Invasive and not suitable for
children.
Pupillary threshold
testing
Function Population, groups of
individuals
Inversely correlates with serum vitamin A values in the low-deficient range and the concentration of
vitamin A in the retina. Noninvasive and can be used in field conditions
Dietary assessment Exposure Population, individual with
repeated testing
Qualitative measure of exposure. Provides useful information to support biochemical biomarkers.
Seasonality of fruit and vegetables must be included.
1 Data are from reference 185. BOND, Biomarkers of Nutrition for Development; RBP, retinol-binding protein.
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(214). The hepatic synthesis of RBP is depressed during zinc
deficiency (216), which results in lower plasma retinol concentra-
tions that confound measurements in zinc-deficient individuals.
Pregnancy lowers serum retinol concentrations through hemo-
dilution. In Indonesian women, serum retinol concentrations
<0.7 mmol/L were associated with positive MRDR tests during
lactation, reflecting low liver retinol stores (217), whereas during
pregnancy a lower cutoff of <0.53 mmol/L was associated with
positive MRDR values (218). This likely reflects hemodilution
from the increase in intravascular volume during this physiologic
state.
Use in program evaluation. Serum retinol distribution
curves are used to evaluate program impact (111). However, the
lack of change in serum retinol distribution over time in several
countries that have sustained >70% coverage with vitamin A
supplementation has raised the concern about the appropriate
TABLE 8 Comparison of sample processing among common biochemical biomarkers of vitamin A
status1
Difficulty of
sample collection
Difficulty of
sample transportation
Technical
analysis
Relative analysis
costs
Analytical
accuracy
Serum retinol ++ ++ ++ $ **
Serum RBP ++ ++ + $ *
DBS retinol + + ++ $ *
DBS RBP + + + $ *
Breast-milk retinol2 + ++ +++ $$ **
Dose-response tests3
RDR ++ ++ ++ $$ ***
MRDR ++ ++ ++ $ ****
Isotope dilution +++ ++ ++++ $$$ *****
Liver analysis2 +++++ ++ +++ $$ *****
1 The greater the number of ‘‘+’’ the greater the difficulty; the greater the number of ‘‘*’’ the more sensitive the analysis and accuracy to determine
vitamin A status; the greater the number of ‘‘$’’ the ‘‘greater the relative costs of the assay in regards to sample number and the instrumentation
involved.’’ DBS, dried blood spot; MRDR, modified relative dose response; RBP, retinol-binding protein; RDR, relative dose response.
2 Breast-milk retinol requires saponification. Liver analysis either requires saponification or lengthy analysis times to add together the variety of retinyl
esters found in humans.
3 The RDR test requires 2 blood samples for analysis, making it logistically more expensive than theMRDR, but theMRDR requires procurement of
3,4-didehydroretinyl acetate.
TABLE 7 Overview of currently available biomarkers for the assessment of vitamin A nutrition1
Biomarker name
Usefulness assessment2
Exposure Status Function Effect
Research Clinical Program Research Clinical Program Research Clinical Program Research Clinical Program
Dietary assessment ++ 0 + 0 0 0 0 0 0 0 0 +
Functional tests + + + + + + ++ ++ + + + +
Dark adaptation
Electroretinography
Pupillary threshold
Biochemical tests
Serum retinol + + + ++ ++ + ++ ++ 0 + 0 +
RBP
Dried blood spots ++ ++ 0 +++ ++ ++ ++ + 0 0 0 +
Breast-milk retinol + + + + + + 0 0 0 + 0 +
RDR 0 0 0 + 0 0 + + 0 + 0 +
MRDR 0 0 0 ++ + ++ ++ ++ ++ ++ ++ ++
Isotope dilution ++ 0 0 ++ 0 + 0 0 0 ++ 0 +
Serum retinyl esters + + + + + + 0 0 0 0 0 0
Liver samples + + 0 + + 0 0 0 0 0 0 0
Radio-isotopes + 0 0 + 0 0 + 0 0 + 0 0
Proteomics or nutri-genomics3 ? ? ? ? ? ? ? ? ? ? ? ?
1 Usefulness assessment uses the following grading system: 0, Not useful for the specific purpose; +, Useful to some extent and in certain population groups, but either not
commonly used or has important disadvantages (e.g., no reference values); ++, Useful in certain population groups, often used with some limitations (e.g., lack of specificity or
sensitivity); +++, Useful, often used in relevant population groups, with no or only minor limitations; ?, Unknown utility for vitamin A status assessment at this time. MRDR,
modified relative dose response; RBP, retinol-binding protein; RDR, relative dose response.
2 Exposure means that the biomarker responds to dietary vitamin A intake, status means that the biomarker measures vitamin A status, function means that the biomarker
measures a shift in function, and effect means that the biomarker is affected by deficiency of vitamin A. Research means that the biomarker can be used in research settings for
evaluation and intervention outcomes, clinical means that the biomarker can be used in clinical settings at the individual level, and program means that the biomarker is applicable
to program evaluations that usually include population assessments with large numbers of individuals.
3 Not discussed systematically in this article.
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indicator (219). For this reason, the impact of supplementation
programs is not measured by a change in the prevalence of low
serum retinol concentrations but may be better served by
evaluating coverage rates. Retinol concentrations may respond
to sustained, improved dietary intakes and therefore can guide
programmatic decisions about whether to maintain or change
interventions (219). Thus, the use of serum retinol distributions
among preschool children from cross-sectional surveys to assess
the need for vitamin A interventions is still recommended.
Furthermore, it is important to determine whether serum retinol
concentrations are being affected by the acute-phase response to
evaluate its influence on the prevalence of low concentrations
(35, 220).
With respect to monitoring the impact of widespread
fortification and interventions that increase dietary intake,
serum retinol distribution may be expected to shift; thus, serum
retinol is an appropriate indicator of response to these programs
(111). The Global Alliance for Vitamin A outlined a framework
for shifting from universal high-dose supplementation toward
other interventions to improve dietary intake. The Global
Alliance recommended that scaling back supplementation could
occur in vulnerable populations when the government can verify
Adequate Intakes from diet and other interventions. By using
WHO prevalence cutoffs as a guide, a threshold of documented
and verified prevalence of <5% for serum retinol concentrations
<0.7 mmol/L was proposed as a basis for scaling back or
withdrawing universal supplementation to children <5 y of age
(219). To date, this recommendation has not been evaluated by
the WHO.
Use in intervention research. The response of serum
retinol concentrations to interventions will rely heavily on the
underlying vitamin A status. If serum retinol concentrations are
initially low, and the population is not experiencing a high
degree of inflammation, serum retinol concentrations may
increase. Serum retinol concentrations in Indonesian children
improved significantly when they were fed retinol-rich foods
and provitamin A–containing orange fruit or leafy vegetables
and carrots compared with a low vitamin A–fed group (78).
Nonetheless, in Zambian children of a similar age with adequate
to hypervitaminotic vitamin A stores, serum retinol did not
respond to an intervention when given as either when given the
RDA as supplemental retinyl palmitate or when fed orange
biofortified maize 6 d/wk (85).
Use in clinical application. Serum retinol concentrations
are affected by infection status. RBP is a negative acute-phase
protein, and thus retinol and RBP concentrations decrease
FIGURE 6 The definition of vita-
min A status related to liver vitamin
A concentrations and the range of
liver reserves in which the vitamin
A biomarker has utility in predict-
ing vitamin A status. In the past,
0.7–1 mmol/g was considered ex-
cessive, but until more biologically
meaningful data are generated
this range is considered high.
Updated in 2015. VA, vitamin A.
Reproduced from reference 186
with permission.
FIGURE 7 The rod-cone break period measured
in luminance (log micro-microlamberts) occurs in
,10 min in normal individuals when placed in a dark
room. Vitamin A–deficient subjects have a higher
luminance need to see in the dark as depicted by
patients (n = 13) with chronic small intestinal
disease compared with the range of 7 controls.
Reproduced from reference 196 with permission.
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during the acute-phase response (35, 220). Therefore, serum
retinol has very little utility to diagnose vitamin A deficiency
when individuals have an infection. In addition, serum retinol
concentrations are homeostatically controlled over a broad
range of liver reserves and thus are best used at the population
level as detailed above.
Use of serum retinol concentrations in epidemiologic
studies. Serum retinol concentrations are determined and have
been evaluated in epidemiologic surveys. A recent evaluation of
NHANES III data in adults $50 y of age determined that serum
retinol concentrations that were either <1 mmol/L or >2.8 mmol/L
were associatedwith increased risk of all-cause and cardiovascular
or coronary artery disease–related mortality (221). The signifi-
cance of these findings is not entirely known. In otherwise well-
nourished individuals who are not experiencing inflammation,
serum retinol concentrations <1 mmol/L may reflect vitamin A
deficiency (214). It appears that serum retinol concentrations are
increasing over time in well-nourished Americans, which may be
associated with increased catabolism (140) due to the fortification
of a variety of foods andmultivitamin supplement use that increase
total body stores over time (222).
Effect of infection or inflammation on serum retinol
concentrations. The acute-phase response to either infection or
inflammation affects retinol homeostasis. The acute-phase re-
sponse on micronutrient status markers has been reviewed (223,
224). Currently, concentrations of C-reactive protein (CRP) and
a1-acid glycoprotein (AGP) have been used to identify infection
stage according to a proposed published paradigm: elevated CRP
alone indicates the incubation or early phase of an acute infection,
elevated CRP and AGP indicate early convalescence, and elevated
AGP only indicates late convalescence. These inflammation stages
have been used to correct serum retinol concentrations or to choose
lower cutoffs for serum retinol as a marker of deficiency (225).
During early convalescence, serum retinol concentrations are
shifted further to the left than during late convalescence or
incubation (Figure 9) (220). In Zambian (226) and Indonesian
(227) children, lower serum retinol concentrations were associ-
ated with elevated CRP, whereas the MRDR test response was
not. In contrast, Thai children who had low rates of inflammation
were able to maintain serum retinol concentrations >0.7 mmol/L,
even though mean liver reserves were 0.09 6 0.05 mmol/g liver,
which was determined by retinol isotope dilution (220, 228).
RBP. Plasma RBP, sometimes referred to as RBP4, is the transport
protein for retinol in the blood and is found in many vertebrate
species. Rodents and pigs are particularly useful models for
translation to human studies (229). RBP is synthesized primarily in
hepatocytes as the apo-form and secreted bound to retinol as the
holo-RBP complex to provide vitamin A to peripheral tissues.
holo-RBP binds 1 molecule of retinol (230). RBP is also synthe-
sized in other cells (e.g., adipocytes) (231), although the magnitude
of the contribution of such sites to plasma RBP is not clear. RBP is
not secreted from the liver when retinol is limiting (i.e., when
vitamin A stores are low) and RBP accumulates (186, 188). This is
the biology by which the dose-response tests work (described
below). The release of the holo-RBP complex is interrupted during
inflammation, resulting in lower plasma retinol and RBP concen-
trations than would be seen without inflammation (95). To
account for this phenomenon, which can lead to false identifi-
cation of someone as being vitamin A deficient, serum markers
of inflammation (e.g., CRP, AGP) can be used to identify
individuals with inflammation. Currently, a consensus on how to
deal with this problem has not been reached, although some
suggest adjusting serum retinol or RBP concentrations with the
use of acute-phase proteins (35) or adjusting cutoffs to modify
prevalence (220). It is possible that this transient decrease in
serum holo-RBP during infection has a significant effect on
transport and may cause a functional deficiency in peripheral
tissues, but this has never been convincingly shown.
Plasma RBP is normally ;85% saturated with retinol (i.e.,
85% holo, 15% apo), although this differs on the basis of the
degree of adiposity (232). holo-RBP forms a noncovalent
complex with transthyretin, the transport protein for thyroid
hormones. The association between holo-RBP and transthyretin
strengthens and stabilizes the binding between retinol and RBP
(133, 233) and prevents holo-RBP from loss to glomerular
filtration in the kidney (234). In addition, the transthyretin-RBP
complex is sufficiently large that it remains in the blood rather
than being filtered into the kidney tubules by passing through the
fenestrations of the glomerulus. apo-RBP, which is a small
protein with a molecular weight of 21 kDa, does pass into the
tubular filtrate and is usually reabsorbed by the proximal tubular
epithelium via the transport protein megalin. Under some condi-
tions, this reabsorption process is disrupted (e.g., high fever, use of
aminoglycoside antibiotics) and low-molecular-weight serum
proteins, including RBP, appear in the urine. Substantial vitamin
A can be lost in the urine during illness accompanied by high fever
(235) or in some genetic diseases that affect tubular function (236).
This may increase the risk of vitamin A deficiency in individuals
who do not have adequate liver stores to draw from. In subjects
with kidney disease, the glomerular filtration rate decreases,
resulting in an increase in the serum concentration of apo-RBP
(237) and a lower percentage of saturation with retinol than the
typical 85%. This altered ratio would decrease the utility of RBP
as a surrogate indicator of serum retinol concentration.
In obese individuals, serum RBP concentrations appear to be
affected by adipose tissue, and some consider RBP to be an adi-
pokine, secreted by adipocytes and affecting other tissues, perhaps
directly affecting insulin resistance (176). In studies in adults and
adolescents, serum RBP was positively correlated with BMI,
visceral adiposity, and insulin resistance, which are components of
metabolic syndrome, and even inflammatory markers (although
inflammatory markers have a negative association with RBP
outside of obesity). Thus, serumRBPmay be particularly unsuitable
for extrapolation to serum retinol concentrations during obesity,
because the concentration of apo-RBP not bound to retinol may
increase relative to holo-RBP (232, 238). Note that in high-income
FIGURE 8 The electroretinogram response in the mvolts is gener-
ated by light stimulation of the retina and occurs in milliseconds. The
electroretinogram is characterized by a negative ‘‘a’’ wave originating
from the photoreceptor inner segments followed by a positive ‘‘b’’
wave, which originates from the retinal bipolar cell layer. The
electroretinogram amplitude is proportional to the intensity of light,
the degree of dark adaptation, the number of photoreceptors, and the
rhodopsin visual pigment concentration. Reproduced from reference
204 with permission.
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countries, where most of these obesity studies were conducted, the
risk of vitamin A deficiency is low. However, in countries un-
dergoing economic and nutritional transitions, obesity may coexist
with vitamin A deficiency, and it is unclear how RBP would
perform as an indicator of serum retinol concentrations in these
settings. For example, if adipocyte-derived RBP tends to be apo-
RBP not bound to retinol, this phenomenon would produce false-
negative results, indicating adequate serum retinol in obese subjects
when, in fact, vitamin A–deficient concentrations are present.
Retinol from holo-RBP is transported into cells via the RBP
receptor protein STRA6 (239), and this process may be inhibited
by transthyretin binding to RBP (240). The implications of this
for vitamin A transport to tissues are not yet clear. STRA6 may
also initiate intracellular signaling when RBP is bound (241), a
newly suggested role for this receptor, and may thus affect
cellular function in novel ways that may not be directly related
to vitamin A transport. It is not known if STRA6 contributes to
the decrease in holo-RBP that occurs during inflammation.
Assessment of deficiency. Serum RBP is used as a proxy
for serum retinol concentrations in the identification of vitamin
A deficiency. As discussed above, serum retinol correlates with
liver vitamin A stores only when liver stores are very low. When
stores are replete, serum retinol concentrations are homeostati-
cally regulated and do not correlate with liver stores. Because the
RBP-retinol complex is released by the liver as part of this
homeostatic process, serum RBP correlates closely with serum
retinol concentrations, at least in subjects with normal kidney
function who are not obese. Quantitative assessment of RBP
concentration is cheaper and easier than the standard method
for measuring serum retinol concentrations (HPLC analysis).
Serum RBP can be measured by immune-detection methods
because highly specific antibodies are available. The most
common methods include ELISA, which is useful for small
laboratories, and other methods (e.g., nephelometry) that are
more commonly used in automated clinical analyzers found in
hospital or reference laboratories. Many of the commercially
available reagents and kits are intended for serum, but kits are
also manufactured for measuring urinary RBP as an indicator of
kidney proximal tubular function.
RBP is not always 100% saturated with retinol; therefore, a
1:1 molecular equivalence between retinol and RBP in the blood
does not usually occur. Thus, one cannot generally use the
retinol cutoffs for RBP unless liver stores are hypervitaminotic,
as discovered in Zambian preschool children (85) in whom the
ratio was 1.0 (144). In addition, the added variability in differences
in kidney function (e.g., low glomerular filtration rate can cause an
increase in RBP but not retinol) among subjects as well as the
apparent contribution of adipose tissue to serum RBP (which may
not reflect tissue stores in the same way as liver-derived RBP) make
it unlikely that the same retinol-RBP correlation that might be
observed in 1 population would be appropriate for another. It is
possible that certain populations, such as young children not at
risk of obesity and with normal kidney function, may be relatively
homogeneous with regard to this association, but such associa-
tions have not been systematically examined. Thus, the best
approach for RBP is to take a subset of samples of interest and
measure serum retinol concentrations by HPLC and then use these
data to construct a standard curve to predict serum retinol from
serum RBP in the population of interest. Of course, the sample
should have a wide range of serum retinol concentrations in order
to produce a reasonable correlation (i.e., enough high and low
values to make a standard curve). This could be done by first
measuring RBP in a large number of samples and then selecting
low,middle, and high values for serum retinol analysis. SerumRBP
is not a useful marker of recent vitamin A intake (exposure)
because of its homeostatic regulation by the liver.
Prevalence surveys. Prevalence surveys in nearly all
settings will probably be large enough to benefit from the
economy of the RBP method and should also be large enough to
select a subset for retinol analysis for construction of a standard
curve. Most populations will contain individuals with current or
recent acute infections or chronic inflammation associated with
obesity or chronic disease, which all depress serum retinol. Thus,
analysis of acute-phase proteins, such as CRP and AGP, is
recommended.
Surveillance. Surveillance raises the issue of time-sensitive
analysis of data that may preclude the approach used in surveys
of analyzing a subset for retinol analysis that has been selected
over a wide range of serum RBP concentrations. One approach
may be to perform both assays on early samples from the
surveillance (if the surveillance is going on for months to years
and data are needed periodically). To determine if RBP
measurements are within the diagnostic range of the assay used
and to produce an initial standard curve for predicting serum
retinol from RBP, some of the samples with the highest RBP
concentrations could be diluted by 2- to 4-fold with physiologic
saline and reanalyzed by both the RBP and retinol assays and
used as standards until completion of the survey.
Program evaluation. The issues for program evaluation are
quite similar to those discussed above for surveys.
Intervention research. Intervention research in communi-
ties raises many of the same issues as discussed for surveys but
also allows one to consider the use of only RBP to compare 2
interventions—for example, in cases in which external validity
(i.e., correlation with actual retinol concentration) may not be
necessary (although it is probably always desirable). Thus, one
could use RBP by itself in such a situation to compare multiple
intervention groups, assuming the subjects in the intervention
groups are relatively homogenous with regard to other charac-
teristics that may affect serum RBP (e.g., age, BMI).
Clinical applications. Serum retinol concentrations should
probably be used in clinical research given that clinical popu-
lations may have underlying medical issues that could affect the
relation between retinol and RBP, such as differences in kidney
function, which may invalidate the use of RBP.
Epidemiologic studies. The population under study will
affect the decision to use RBP as an indicator of vitamin A status.
For example, in obesity research, serum RBP is considered to act,
perhaps independently of retinol, as amediatory in the development
FIGURE 9 Kernel density estimation visually depicts smoothed
distribution trends in serum retinol concentration shifts (mmol/L) by
infection stage. The acute-phase response lowers circulating concen-
trations of retinol. Adapted from reference 220 with permission.
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of insulin resistance (176); and the retinol-to-RBP ratio may be
lowered due to RBP secreted from adipose tissue unbound to retinol
(232), as discussed above. RBP measurements may not be useful in
populations with a high prevalence of obesity because some of the
RBP would be derived from adipose and not bound to retinol.
However, in most instances, these associations are seen at serum
RBP concentrations that are much higher than those used for the
diagnosis of deficiency.
Dried blood spots as a surrogate of serum retinol
concentration
Historically, serum/plasma retinol was a common indicator of
vitamin A status (242). It correlates with the prevalence and
severity of xerophthalmia and may change in response to
vitamin A interventions if the population being studied has
underlying vitamin A deficiency. Serum retinol concentrations
do have limitations as described above. With current analytical
techniques, it is not necessary to draw venous blood to measure
retinol because <20 mL serum is obtainable from a finger-prick,
which is preferable in some nonresearch settings. The primary
restrictions to the use of serum are maintaining a cold-chain,
transporting and storing samples frozen until analysis, and
requiring separation from whole blood, which can be challeng-
ing in field settings in which electricity may not be available.
The use of dried whole blood as a sample can circumvent the
issues of cold-chain and centrifugation. The measurement of
retinol in dried blood spots (DBSs) makes sample collection
more practical and convenient. The collection of DBSs obtained
from a finger-prick is usually less invasive and more acceptable
than the collection of venous blood. The volume of blood
required for retinol or RBP analysis can also be obtained from
neonates via heel-pricks. The measurement of retinol in the
serum component of the dried blood on the collection card is
associated with serum retinol concentration by HPLC, but a
correction factor is often needed. Its use and interpretation as an
indicator of vitamin A status are subject to the same consider-
ations as serum retinol.
The measurement of retinol on filter paper was first reported
for dried serum samples by Oliver et al. (243). This study
showed the potential for transporting samples without a cold-
chain but still required centrifugation to obtain serum and used a
200-mL serum volume. The measurement of vitamin A in
microsamples of whole dried blood as holo-RBP was first shown
by Shi et al. (244) who used capillary electrophoresis and laser-
excited fluorescence detection. Although an impractical method
for routine use, it showed that the RBP complex protects retinol
in whole dried blood. The analysis of retinol in DBSs was
transferred to HPLC and further refined at Craft Technologies
(245–248). Houze´ et al. (249) reported analyzing DBSs with
electrochemical detection, which may increase sensitivity for
other DBS applications. DBS retinol is measured in several
laboratories internationally. Manuals are available that provide
instructions for DBS collection (250, 251).
Validation studies. Several studies have been performed to
validate the performance of DBS retinol compared with serum
retinol. The first was conducted with matching DBSs and serum
samples collected from 17 adult volunteers (245). The coefficient
of determination (r2) was 0.90 between plasma and DBS retinol
(245). Another small study performed in 20 healthy Guatemalan
adults also compared capillary with venous blood (246). The
coefficient of determination (r2) was 0.88 between plasma retinol
and capillary DBS retinol, and there was no significant difference
between serum retinol and capillary or venous DBS retinol (246).
For application in the field, DBS retinol was included in a
group of 146 pregnant Nepali women (33). Blood spot retinol
predicted low serum retinol concentrations with a sensitivity of
89.5% and a specificity of 98.4% compared with serum retinol
determined by HPLC (247). In 54 Nepali children, the sensitivity
of DBS retinol was 92.9% and the specificity was 90%
compared with serum retinol concentrations.
DBS limitations. Although DBS retinol is essentially equivalent
to serum retinol under ideal conditions, it carries some limita-
tions that are unique to the DBS matrix, particularly in a field
setting. Liquid serum volumes can be accurately measured and
estimates of serum volume in DBSs are reasonably accurate in a
laboratory setting in which known volumes can be spotted
reproducibly. However, obtaining DBSs directly from the finger
of a child is less than ideal. DBS samples that are not saturated,
have layers of blood, or form ‘‘halos" will prevent an accurate
estimation of the volume on the basis of a circular punched hole
of the blood spot. This variability can be corrected by estimating
volume on the basis of sodium content in the punch (248).
Furthermore, there is an initial decline of ;20% in retinol
during 7–10 d after spots are collected (245, 248). Adjustment
of the DBS values by 20% brings the average retinol value into
agreement with the average serum retinol concentration; however,
this apparent loss will vary somewhat from sample to sample. It is
recommended to calibrate the DBS retinol analysis with standard
blood spots of known serum retinol content, thereby adjusting for
the decline in recovery with the use of the same sample matrix.
Just as environmental factors can influence the stability of serum
retinol, there are factors that alter DBS retinol. The collection
manuals cited above discuss these factors. Samples should be kept
away from sunlight, maintained in a low-humidity environment by
including desiccant in sealed plastic bags (e.g., Ziploc; SC Johnson
& Son, Inc.) (248), protected from exposure to elevated temper-
atures (>35C), and maintained at refrigerated temperatures to
prolong retinol stability.
Breast-milk retinol concentration
Breast-milk retinol concentration is a biochemical indicator of
maternal vitamin A status, and it also provides indirect informa-
tion on the risk of inadequate vitamin A intake in predominantly
breastfed infants. In many poor settings, breast milk provides the
sole reliable source of vitamin A for the first 6 mo of life or longer
and can provide a breastfed infant with 435–500 mg dietary
vitamin A (34), which is regarded as an adequate amount of
vitaminA during infancy (57). Even if breast milk contains half this
amount in undernourished settings (34, 252), it can still provide
clinically protective amounts to infants and toddlers (253, 254).
Breast-milk retinol concentrations can be used to assess
vitamin A deficiency at the population level, to assess the efficacy
of vitamin A interventions, and to monitor and evaluate vitamin
A intervention programs. Breast-milk retinol concentrations
#1.05 mmol/L or #8 mg/g milk fat are considered inadequate,
and vitamin A deficiency is considered a moderate public health
problem when the prevalence of inadequate milk retinol concen-
trations is $10% to <25% (242). Breast-milk samples are
relatively easy to obtain, and milk vitamin A can be measured in
community settings by using a portable fluorometer (255) or in
more sophisticated laboratory settings by using HPLC (255, 256).
It is important to carefully define the study population when
breast-milk retinol is used as an indicator of vitamin A status in
areas in which breastfeeding is common until $6 mo of age
(242). Methods for selecting participants and estimating sample
size will vary depending on the purpose of the study. Briefly,
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factors that should be considered in selecting a study population
include age, stage of lactation, geographic location, season, and
pregnancy status. The collection of information on other factors
that may affect milk vitamin A is also useful, such as socioeco-
nomic status, anemia, morbidity, exposure to postpartum high-
dose or daily vitamin A supplements, andmaternal dietary vitamin
A intake.
Stage of lactation, time of day, and ‘‘fullness’’ of the breast
can affect milk retinol concentration; thus, the method for
collecting milk samples should be carefully considered when
planning a study (257). Because concentrations of vitamin A are
high in colostrum and early milk (#1 mo postpartum), it is
important to collect milk samples at >1 mo postpartum when
milk retinol has stabilized. Vitamin A is found in milk fat, and
milk fat varies throughout the day and tends to be highest later
in day. In addition, because milk fat increases during a feeding
episode, the concentration of vitamin A is higher in hind-milk.
Thus, the collection of milk samples is often standardized in
relation to time of day and time since last feeding episode, as
described below. Milk fat is also often measured so that milk
vitamin A concentration can be expressed per gram of milk fat;
this can be accomplished by determining the creamatocrit, and
commercial centrifuges are available specifically for this purpose
(258).
The sampling method for collecting breast milk should be
chosen carefully and will depend on the purpose of the study and
the resources available (257). In general, ‘‘casual’’ milk samples
(;5–10 mL) can be collected by hand-expression, and the
vitamin A concentration of milk can be expressed per gram of fat
to account for fat variability. This method of milk collection is
more feasible for large-scale surveys and surveillance programs.
‘‘Full’’ milk samples can be collected by emptying all of the milk
from a breast that has not been used to feed an infant for $1 h.
The full milk sample is considered to be more representative of
what the infant consumes in a feeding episode. A sample of well-
mixed milk (;5–10 mL) is taken from the full milk sample for
analysis of vitamin A concentration and the remaining milk
is returned to the mother to spoon-feed to her infant. The
collection of full milk samples is usually standardized to time of
day and to time since the last feeding episode ($1 h since last
feeding) to minimize variability in milk fat, and the vitamin A
concentration is expressed per unit volume and/or per gram of
fat. Full milk samples are generally recommended for longitu-
dinal studies that aim to determine the efficacy or effectiveness of
interventions for increasing vitamin A status. However, the milk
sampling method (full compared with casual) may affect the
sensitivity of the indicator for detecting a change in vitamin A
status in response to an intervention. In lactating Bangladeshi
women, the milk retinol concentration of casual milk samples,
when expressed per gram of fat, was more sensitive for detecting
a response to a vitamin A intervention than the milk retinol
concentration of full milk samples, expressed per gram of fat or
per unit volume (259).
Uncertainty exists about whether the expression of milk
retinol concentration on the basis of volume or fat affects the
sensitivity of the indicator to detect an intervention response. In
Indonesian women, milk retinol, expressed per gram of fat, was
more sensitive for detecting a change in vitamin A status in
response to an intervention than was milk vitamin A, expressed
per unit volume, in full milk samples (260). In contrast, milk
vitamin A, expressed per unit volume, was more responsive than
milk vitamin A, expressed per gram of fat, in full milk samples in
a later study in Indonesian women (261). Theoretically, a full
milk sample, when standardized to time of day and time since
last feeding, should be a more sensitive indicator for detecting a
change in vitamin A status in response to an intervention.
However, until the potential effect of the milk sampling method
on the responsiveness of the indicator is better understood, it
may be best to use both casual and full milk sampling methods
and to measure milk fat when assessing efficacy or effectiveness
of an intervention in longitudinal studies.
Milk should be processed carefully to ensure that represen-
tative aliquots of milk are taken for the vitamin A and fat
analyses. Milk should be processed away from direct light to
prevent photodegradation of vitamin A. It is very important to
mix the fresh milk well so that the cream layer is evenly
distributed throughout the aliquot that is taken for measurement
of the vitamin A concentration. Because the vitamin A is found
in the milk fat, the distribution of fat in the aliquot of milk that is
taken for analysis can affect the measurement. In general, milk
samples (;1 mL) are stored in cryovials at 220C (or colder)
until analyzed for vitamin A content. Because it can be difficult
to fully homogenize milk samples that have been previously
frozen, the precise aliquots of milk that will be used for
measuring the vitamin A content can be prepared and stored to
avoid the need to homogenize previously frozen milk samples
(256). The vitamin A content of fresh milk samples can also
be analyzed, and this is feasible with the use of a portable
fluorometer.
Relative-dose-response tests
Liver reserves are frequently defined as the ‘‘gold standard’’ for
defining vitamin A status (34, 186). The liver has a large storage
capacity for vitamin A, and in humans with adequate status
;90% of vitamin A is stored in the liver in specialized fat-
storing cells (Ito cells) (121). The MRDR test and its precursor,
the relative-dose-response (RDR) test, are based on hepatic
accumulation of apo-RBP during vitamin A inadequacy. Hepatic
RBP synthesis is independent of vitamin A status, but its release
from the liver is dependent on vitamin A status (188, 262–264).
When vitamin A intake is inadequate and liver reserves are low,
apo-RBP accumulates (188). In rats fed a vitamin A–deficient
diet, apo-RBP accumulated in the liver well before serum retinol
concentrations decreased and the liver was depleted (188). In
vitamin A–deficient rats, apo-RBP accumulation reached a
steady state concentration (188, 262). In response to newly
ingested vitamin A, the accumulated apo-RBP binds retinol (or
3,4-didehydroretinol in the MRDR test) and becomes rapidly
mobilized from the liver to the serum as the holo-complex (188).
The accumulation of apo-RBP, the rapid release of holo-RBP
after ingestion of vitamin A, and the subsequent increase in the
plasma during deficiency provide the biological framework for
both of the dose-response tests.
RDR test, precursor to the MRDR test. The RDR test involves
administering an oral dose of retinyl ester (22) and collecting a
serum sample just before dosing and again 5 h after dosing. The
RDR value, expressed as a percentage, is calculated as [(A5 –
A0)/A5] 3 100, where A5 is the serum retinol concentration at
5 h postdosing and A0 is the concentration just before dosing
(22). An RDR value of 20% is often considered a vitamin
A–deficient response (210). An oral dose of 1 mg retinyl acetate
is recommended in children (265). The RDR test was validated
against liver vitamin A reserves in children with liver disease by
using an intravenous injection (266). Although the RDR test is a
useful indicator, it requires 2 blood samples/subject, and an
accurate RDR value is dependent on the correct analysis of both
serum samples, usually by using HPLC. Often, negative values
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are obtained and these are difficult to interpret (267). One study
showed that the RDR test is not reliable in children who are
recovering from pneumonia who still have an active acute-phase
response (CRP >10 mg/L) (268).
MRDR test. The MRDR test uses 3,4-didehydroretinyl acetate
(DRA), or vitamin A2 acetate, for the challenge dose, followed
by a high-fat snack to ensure adequate absorption; and a single
blood sample is taken between 4 and 7 h postdosing (27, 265,
269, 270). As little as 200 mL serum can be analyzed for 3,4-
didehydroretinol (DR) and retinol by using HPLC on the same
serum sample (271), and 100–150 mL has been used with young
infants. The structure of DR is similar to retinol, and the only
difference is a double bond located in the 3–4 position on the
b-ionone ring of DR. This structural difference between DR and
retinol provides enough difference in polarity to allow them to
separate from one another with the use of HPLC. In parallel to
retinyl esters, DRA is hydrolyzed in the small intestine to DR,
which is taken up by enterocytes and esterified to form various
didehydroretinyl esters that are incorporated into chylomicra,
enter the lymph, and then enter the general circulation. Once at
the liver, the esters are de-esterified to form DR, which can bind
to apo-RBP and be released into the serum or can be re-esterified
and stored in stellate cells. Standard doses of 5.3 mmol DRA are
recommended for children <6 y old, 7.0 mmol DRA for children
aged between 6 and 12 y, and 8.8 mmol DRA for adults (265).
The ratio of DR to retinol in serum is called the MRDR value
and is used to indicate liver reserves. Values $0.060 at the
individual level usually indicate insufficient liver reserves (#0.1
mmol retinol/g), whereas values <0.060 are indicative of sufficient
liver reserves ($0.1 mmol retinol/g) (186). Group mean ratios of
<0.030 appear to correlate with adequate status. The lower ratio
(0.030) that indicates better liver reserves was established by
performing the MRDR test on several groups of well-nourished,
healthy American children and adults with presumably adequate
liver reserves (269, 270). In a study in 3 adults and 2 children (269),
the highest MRDR value obtained was 0.023. In a time-course
study involving 12 American children whose blood samples were
collected between 4 and 7 h postdosing (270), only 2 children had
ratios >0.030. Nine healthy American adults and 1 child all had
MRDR values <0.030 and normal conjunctival impression cytol-
ogy, which measures abnormal pathology of the eye due to poor
vitamin A status (209–212, 272). The highest MRDR value of this
group was 0.021, and the ratio was reproducible. Cumulatively,
these data led to the recommendation that healthy, well-nourished
individuals with sufficient liver reserves should invariably have
MRDR values <0.030 (265, 270). The choice of an MRDR value
$0.060, indicating poor liver reserves, was based on a comparison
of MRDR values obtained from Indonesian children before and
after the administration of a high dose of retinyl ester (200,000 IU
retinyl palmitate) (110, 210).
In a study in 13 lactating Indonesian women whose serum
retinol concentrations were <0.70 mmol/L, all but one had an
MRDR value $0.060 (218). Another study that used the cutoff
of$0.060 examined 19 lactating Indonesian women before and
after vitamin A supplementation (8.4 mmol daily in capsule form
for 35 d) (273). The women were tested by using the MRDR test
3 times before supplementation; the prevalence of vitamin A
deficiency was between 70% and 83%, and the mean MRDR
value did not differ at the 3 assessments. After supplementation,
the prevalence of vitamin A deficiency decreased to 13% with
the use of the MRDR test. No woman in the entire group had a
preintervention MRDR value <0.030, the cutoff value estab-
lished for a well-nourished and healthy population, but 10 had
MRDR values <0.030 postintervention, indicating that these
women showed a dramatic improvement in liver stores.
The MRDR test has been used to assess the vitamin A status in
many population groups, including Senegalese infants (274),
Zambian (226, 275) andAmerican (270, 276) children, Indonesian
(218) and American (277) pregnant women, and Indonesian (217,
273) and Bangladeshi (278) lactating women, among others.
Although useful, it does not give a quantitative estimate of liver
reserves but does offer a semiquantitative range in groups who
have marginal to adequate vitamin A status (186). The MRDR
test, as currently applied, is not useful in defining vitamin A status
above adequacy (Figure 6). Nonetheless, it is more sensitive to
changes in vitamin A status than serum retinol concentrations
alone and will respond better in interventions when liver reserves
change from marginal to adequate (110). Furthermore, it can be
used in a randomly selected subset of individuals in population
surveys to qualify the underlying vitamin A status (242).
Retinol isotope dilution
Isotope dilution is a quantitative method for determining total
body stores of vitamin A (279, 280). It can be used to determine
total body stores of vitamin A for population monitoring or
program evaluation by using a randomly selected subsample who
are not experiencing fever. In research settings, isotope dilution
testing can be paired to evaluate the efficacy of interventions (279,
281). Although technically sophisticated and requiring specialized
mass spectrometric equipment, isotope dilution has the advantage
of being the most sensitive test to measure vitamin A status and
intervention impact on vitamin A reserves while being minimally
invasive because it only requires blood samples (279–281).
Furthermore, because of increased sensitivity, lower numbers of
subjects can be assessed in intervention studies (279).
In brief, the technique involves administering a dose of
deuterium or 13C-labeled retinyl acetate. For some 13C applications
(or for repeated assessment with the use of deuterium), a baseline
blood sample is taken to determine background enrichment. After
the dose is allowed to mix fully with the body stores of vitamin A,
another blood sample is taken. Various types of MS in conjunction
with separation by GC or LC are used to measure isotopic
enrichment in the serum (279–282). The serum (or plasma) is then
analyzed to determine the ratio of the labeled to native retinol
(tracer-to-tracee ratio) (283). The higher the total body stores, the
more the isotope is diluted, resulting in a lower tracer-to-tracee
ratio. The total body stores of vitamin A can then be calculated
from these data (283). Isotope dilution has been validated against
liver reserves of humans in the United States (28) and Bangladesh
(284), in rats (285), and in rhesusmonkeys (286). The test is able to
work over a wide range of physiologic human conditions, from
deficient (<0.1 mmol/g liver) through hypervitaminotic concentra-
tions (>1 mmol/g liver) (85), and in some cases for toxic con-
centrations (>10 mmol/g liver) (286) (Figure 6).
The duration of assessment for total body stores is dependent
mainly on the equilibration period. Current applied periods of
equilibration are 14–21 d for adults and 14 d for children. This
allows the vitamin A to fully mix and therefore provides a
quantitative reading of the vitamin A in the whole body (279–
281). Accurate qualitative assessment can also be made with 3-d
equilibration (287), and researchers have attempted to further
refine the shorter 3-d equilibration period to make this method
more field-friendly (288).
To measure efficacy, the paired isotope dilution technique is
used to compare the change that occurred in total amount of
vitamin A in the body during the intervention (281). Each
subject serves as his or her own control, which maximizes the
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power of studies. Isotope dilution can be used to detect even small
differences in treatment groups, making it a powerful technique to
evaluate interventions (281, 289). Amain consideration that needs
to be taken into account during the test is the utilization rate of
vitamin A in the body. The individuals utilization rate changes
with age, and this is reflected in the calculations depending on the
subject population (280, 281). Furthermore, in some studies,
subjects are placed on a low vitamin A diet before the dose and
during the equilibration to minimize interference from incoming
dietary vitamin A on the isotope ratio (85, 290).
Some possible confounders of the test include food ingested
before the blood sample, co-micronutrient deficiencies, and
inflammation. If large amounts of vitamin A are ingested within
a few hours before the blood draw, this vitamin Awill dilute the
isotopically labeled vitamin A and affect the results. To prevent
interference, blood draws are preferably done while the subject
is fasting, although sometimes this is not practical in infants and
children. Inflammation causes more rapid removal of vitamin A
from the body and altered vitamin A metabolism (291), which
may confound the results obtained from the test. Inflammation
can be monitored by taking temperatures and/or measuring CRP
and AGP concentrations in subjects (85, 281).
The strength of isotope dilution over other vitamin A assess-
ment techniques is that it is both quantitative and sensitive.
Although other vitamin A status indicators may only be able to
qualitatively diagnose a subject as deficient or not deficient, isotope
dilution can quantitatively reveal what the total body stores of
vitamin A are from deficiency through hypervitaminosis (186, 279)
(Figure 6). This makes isotope dilution an ideal technique for
measuring intervention impact or obtaining accurate measures of
liver reserves. It must be noted, however, that the interpretation is
best used at the group level and not at the individual level (280,
281). This becomes especially critical if a researcher is investigating
excessive concentrations of vitamin A, because these are outside
the range of other vitamin A tests (186). Because vitamin A
fortificants are preformed vitamin A, monitoring excess vitamin A
status is important in the near future (222).
For isotope studies, a sample size of 30 subjects/treatment
group may yield enough power for supplement studies (279).
However, the sample size should be increased for studies that
involve provitamin A carotenoids and should be based on a
power analysis (85, 281).
Analysis of the samples can be intensive and can be a major
drawback. For example, some isotope dilution techniques require
the retinol to be extracted from serum and purified by HPLC to
remove impurities before injection on the GC (85, 286). Further-
more, most deuterium-labeled vitamin A techniques require
derivatization before analysis (284, 292). All methods derive the
tracer-to-tracee ratio, and the calculations used to estimate total
body stores or total liver reserves are similar (283).
This test can be carried out as easily as any other test that
requires venous blood samples that can be drawn in the field.
The blood should be kept cold (not frozen) until centrifuged to
prepare serum, which should be frozen and maintained at 270
to 280C until analysis (293). For transport, liquid nitrogen
tanks or dry ice may be used. The isotopically labeled dose
should be kept frozen until administration. A positive displace-
ment pipette will be required to administer an accurate dose to
each subject or capsules can be prepared ahead of time. The dose
should preferably remain at a constant temperature throughout
dosing to ensure that the volume stays constant for all subjects.
If there is a large prevalence of disease or other infections,
care must be taken when interpreting the data. The test relies on
the assumption that absorption and metabolism of vitamin A,
which are both affected by infection, are constant throughout
the equilibration period; and major differences between subjects
could cause error in calculations. Monitoring infections and
inflammation is critical for ensuring accurate data (281, 291).
The concurrent use of CRP and AGP can determine the degree of
inflammation in the participant (223), and adjustments can be
made to account for the presence of inflammation (85, 283).
Retinyl esters as a measure of vitamin A excess
Although many biomarkers are available to assess whether or
not vitamin A deficiency is present in an individual or a
population, only a few biomarkers are presently available to
assess vitamin A toxicity. In addition to isotope dilution
techniques, the use of fasting serum or plasma retinyl esters is
a qualitative measure of hypervitaminosis A. Retinyl esters as a
biomarker of vitamin A excess was first described in 3 patients
with clinically apparent, chronic hypervitaminosis A in whom
up to 67% of circulating vitamin A was in the form of retinyl
esters (294). Although, retinyl esters are the principal form of
dietary preformed vitamin A, they only appear at high concen-
trations in the chylomicra in plasma shortly after a high vitamin
A- and fat-containing meal unless liver reserves are excessive.
The liver normally clears the retinyl esters within chylomicron
remnants from the general circulation, a process that may take
several hours after ingesting a meal or a vitamin A-containing
supplement. However, the liver storage capacity for vitamin A is
not infinite and can become overwhelmed by ingesting, either
acutely or chronically, too much vitamin A (51). In this situation,
the liver can no longer clear the retinyl esters from the circulation,
and retinyl esters begin to spill out from (or are not sequestered by)
the liver into the circulation. Some of the circulating retinyl esters
become converted to free retinol (unbound to RBP). Free retinol in
the circulation is highly toxic to cell membranes, and vitamin A
toxicity can thus be manifested by a myriad of signs and sym-
ptoms: liver damage, hepatomegaly, bone demineralization, skin
rashes and desquamation, anemia, alopecia, and increased cere-
bral spinal fluid pressure, among others (121). The lowest amount
of chronic vitamin A ingestion reported to cause hepatotoxicity
is 14,000 mg/d. Thus, by using an uncertainty factor of ;5, the
IOM has set the UL for vitamin A at 3000 mg/d (10,000 IU). The
same UL is applied to women of child-bearing age (i.e., 2800–
3000 mg/d) (34).
Plasma or serum retinyl esters can bemeasured by either normal-
or reverse-phase HPLC. The same procedures and precautions
must be used in collecting and handling the blood taken for retinyl
ester determination as for serum retinol determination (295, 296).
Both retinol and retinyl ester concentrations can be obtained in the
same HPLC analysis. However, blood drawn for retinyl ester
determination must be taken when the subject is fasting in order to
correctly interpret the result. Patients with hypertriglyceridemia
are at increased risk of high circulating concentrations of retinyl
esters associated with the chylomicron VLDL, which may
predispose them to vitamin A toxicity (297). Furthermore, in-
dividuals with RBP gene mutations may also have higher cir-
culating retinyl esters to compensate for low serum retinol
concentrations (298).
In one study, the normal percentage of retinyl ester in fasting
blood plasma was reported to be 11% of the total circulating
vitamin A in people aged 19–59 y and 13% in people >60 y old.
These percentages corresponded to a normal reference range of
#130 nmol/L for young adults and #170 nmol/L for elderly
subjects (299). In NHANES III (1988–1994), a normal fasting
retinyl ester concentration in serum was <244 nmol/L (<7 mg/dL),
which is a higher cutoff for defining vitamin A excess than
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suggested by the Krasinski et al. study (299). However, the
normal percentage of total serum vitamin A as retinyl ester in
HANES III was 10%, which is almost the same as in the
Krasinski et al. study (11%) (299). A lower percentage of 5% of
total circulating retinol as retinyl ester was suggested as a
potential cutoff for children on the basis of a high percentage of
hypervitaminosis A in the community determined with isotope
dilution and should be further investigated (144).
The use of retinyl esters as a biomarker for vitamin A toxicity
has several confounding issues. As stated above, the blood must
be drawn in the fasting state for proper interpretation. Recent
dietary and/or supplemental intakes can cause an increase in
circulating retinyl esters, which can last for 3–5 h after a meal
(depending on the nature of the meal that was ingested). Protein
malnutrition (300), liver disease (301), and hypertriglyceridemia
(297) can all result in high circulating retinyl ester values even
when vitamin A status is normal. Finally, old age alone can result
in impaired clearance of retinyl esters from chylomicron
circulation after a meal, and thus result in higher blood retinyl
ester concentrations for longer periods of time after eating than
in young adults (302). Nonetheless, retinyl esters were not found
to be elevated in a group of postmenopausal women with intakes
of total vitamin A (preformed plus provitamin A carotenoids)
that were twice the US RDA (128).
A fasting retinyl ester measurement is currently the most
widely used indicator of vitamin A intoxication. However, in
geographic areas with a high prevalence of hepatitis, it is not
known how reliable an indicator of intoxication retinyl ester
concentrations are because high circulating concentrations may
reflect vitamin spillage out of an already diseased and inflamed
liver or impaired and delayed uptake of newly absorbed vitamin
A by a diseased liver.
After a meal, even in geographic areas without a high pre-
valence of liver disease, it is not known how early an indicator of
vitamin A intoxication serum retinyl ester measurement is: that is,
by the time high concentrations of circulating retinyl esters appear,
has liver disease from vitamin A overload already occurred from
the high vitamin A intakes? Thus, there is great interest in de-
veloping additional and possibly more reliable indicators of
vitamin A overload.
Liver biopsy or autopsy samples
Liver biopsies to assess retinol concentrations of humans are only
justifiable in special cases (28, 266, 284, 303). Autopsy samples,
on the other hand, should be considered for population monitor-
ing. For example, the addition of vitamin A to milk in the United
States became mandatory in 1978 because of skim and lower-fat
milks, which remove the naturally occurring retinyl esters during
processing (304). Thus, there have been ;4 decades of fortifica-
tion. Furthermore, dietary supplements and other fortified foods
have become popular in the United States (305). Perhaps autopsy
samples could shed light on current vitamin A status in the United
States. This would also be true for other countries that have
introduced successful vitamin A fortification programs, such as
sugar fortification in Guatemala and in Zambia.
Assay-Specific Queries
The previous section covered the biological aspects of the
important biomarkers of vitamin A status. This section briefly
reviews the analytical methods, quality-control measures, and
sample collection, processing, and storage. Comparisons be-
tween the biochemical methods are outlined in Table 8.
Sample collection for serum, plasma, or blood spot
assays
Most vitamin A assessment techniques (retinol, RBP, RDR,
MRDR, and isotope dilution studies) require the collection of
blood to be processed into serum or plasma, saved as DBSs, or,
with anticipated techniques such as iCheck (BioAnalyt), used as
whole blood at the time of collection. Collecting blood can be a
challenge in many populations and may require community
sensitization or appropriate (but never coercive) incentives. An
excellent manual of blood collection procedures and precautions
is available from the WHO (306). Blood volume for vitamin A
assessment depends on the test used. Serum retinol concentration
can be measured in venous or capillary blood, which can be
separated into serum or plasma, depending on whether or not it is
mixed with an anticoagulant. Blood can be spotted onto paper
cards as DBSs.
Venous blood collection is preferable when relatively large
volumes of serum or plasma are desired, especially for higher
volume assays or multiple assays. Venous collection produces a
higher-quality sample than does capillary collection in that the
potential mixing of interstitial fluid is not a concern. Blood can
be collected in a clinic setting, central site, or in a subjects
home. Regardless of setting, care should be taken to ensure the
safety and health of the subject and phlebotomist through the
provision of a hygienic environment and procedures. Care
should also be taken to ensure the integrity of the blood
sample, an issue in particular in field settings—blood collection
and samples should be protected from excessive heat, light, and
oxygen (air). Blood drawing requires specially trained phleboto-
mists. Processing of blood samples requires laboratory staff that
can run a centrifuge, pipet, and maintain accurate records of
sample identifiers.
Supplies include items to keep the blood collection area clean
(gloves for phlebotomist, alcohol swabs, sterile cotton gauze,
bandages) and safe (biohazardous waste disposal and sharps
containers). Venous blood involves the insertion of a needle into
a vein, typically in the forearm, with the upper arm secured with
a tourniquet. Needles should have an appropriate bore size and
length for the subject and may connect directly to a blood
collection container or be connected by tubing (i.e., ‘‘butterfly’’
needles). Blood can be drawn manually into a syringe (and
transferred to a blood collection tube) or may automatically be
drawn into evacuated tubes. Blood collection tubes may contain
additives, such as clot activator for serum or anticoagulant for
plasma. Cold packs and coolers may be required to maintain the
sample until it is processed by centrifugation to separate the
serum/plasma from RBCs. Transfer pipettes with proper tips are
required to remove the serum/plasma to cryovials for frozen
storage in an electric freezer, under dry ice, or in liquid nitrogen.
Proper labels should be used to identify samples.
Capillary blood collection is often preferred when venous
blood collections may be perceived as unacceptable, when
subjects are infants or small children, when only small amounts
of blood are required, or when highly skilled phlebotomists are
unavailable. Capillary blood can be collected from either the
heel (infants) or fingertip by using a lancet and small blood
collection tubes (e.g., Microtainer brand by Becton Dickinson or
Safe-T-Fill by Ram Scientific). Then it is carefully separated into
serum or plasma by using a microcentrifuge or it can be spotted
onto cards designed to store DBSs for future use. The latter
means of sample collection is often considered more convenient,
because it eliminates the need for laboratory processing of whole
blood to serum/plasma because volumes are usually <200 mL.
However, collecting blood as DBSs also requires careful handling
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and may require cold packs and coolers to maintain the samples
until processed. Care should be taken to ensure the integrity of
the blood samples, an issue in particular in field settings, by
protecting them from excessive heat and light. When capillary
blood collection is used to collect blood as DBSs, care must be
taken to ensure that blood spots are thoroughly dried and
protected from humidity. Proper blood collection cards are
required (e.g., Protein Saver 903, Whatman; GE Healthcare).
Desiccant and pouches for packaging the blood spot cards are
required and available from the manufacturer. Proper labels
should be used to identify all samples.
Sample processing and storage
Care must be taken in the proper processing of blood samples to
ensure the integrity of the analytes of interest during collection,
initial processing, storage, and use. In particular, retinol and
carotenoids are sensitive to degradation in the presence of
exposure to UV light and oxygen. There are some processing and
storage requirements that are specific to the collection of serum,
plasma, and DBSs. Centrifugation for serum or plasma prepa-
ration should ideally take place within hours of blood collection,
although limited data suggest that retinol remains stable in
uncentrifuged samples even up to 24 h postcollection at room or
refrigerator temperatures (307). Exposure to excessive shaking,
vibrations, or cold temperatures before centrifugation may
result in hemolysis of the blood. Stability data show that retinol
is stable at 220C or below for up to 15 y (307, 308), whereas
provitamin A carotenoids may be subject to degradation unless
they are kept at temperatures below 240C (307, 308).
Serum. Serum is the supernatant that results when blood is
collected without an anticoagulant and allowed to clot naturally.
Serum is often the preferred matrix for long-term storage of
biospecimens. After venous or capillary blood collection into
anticoagulant-free blood collection containers, blood should be
allowed to clot at room temperature or refrigerated, but not
frozen, unexposed to light. After allowing the blood to clot, the
blood collection tube should be centrifuged to concentrate the
clot. After centrifugation, the supernatant should immediately
be pipetted or poured (if a serum separator tube is used) into a
cryovial and frozen at 220C or below.
Plasma. Plasma is the supernatant that results when blood is
collected with an anticoagulant, such as sodium heparin or
EDTA placed within the blood collection tube. Blood collected
in such tubes must be mixed thoroughly immediately after
collection by gently inverting the tube several times. An
advantage of collecting blood with anticoagulants is that the
whole blood is preserved to allow for other laboratory tests that
require it or for the collection of white blood cells during
processing. A disadvantage is that fibrin clots may form during
long-term storage. The blood sample should be kept at room or
refrigerated temperatures (not freezing), unexposed to light,
until it is centrifuged to separate the plasma (supernatant) from
cellular material. After centrifugation, the plasma supernatant
should immediately be pipetted into a cryovial and frozen
at 220C or below.
DBSs. Capillary blood should be thoroughly spotted into the
circles of a DBS protein saver card after wiping away the first
drop of blood with sterile gauze. The card should never touch
the skin of the participant; rather, there should be sufficient flow
of blood to soak each circle. The cards must be completely dried
after they are spotted before storage; this may be accomplished
by using a customized slotted storage box that allows airflow
around the front and back of the card. Once dried, cards can be
stored in air-tight pouches with desiccant. Although retinol may
be stable when complexed with its binding proteins, the retinol
measured on DBS cards tends to decline by ;20% in the first
week after spotting (248). Freezing DBSs as a precautionary
measure to eliminate potential influences of temperature and
humidity changes should be considered.
Analytical approaches for retinol
HPLC. Reverse- and normal-phase HPLC methods for serum or
plasma retinol determination have been available for decades
(295, 309, 310). By using the reverse-phase approach with
multi-wavelength detection, it is also possible to analyze
carotenoids and tocopherols in the same run. Sample prepara-
tion typically requires protein precipitation, the extraction of the
fat-soluble components by using a liquid:liquid extraction with
hexanes preferably 2–3 times, drying, and reconstituting in
appropriate solvent. Recovery of the analytes of interest through
the extraction process is estimated by using a known amount of
internal standard (e.g., retinyl acetate as a proxy for retinol). The
rate of throughput is highly variable and is limited by multiple
analytes. Processed samples are typically injected by using an
autosampler. Retinol is visible at 325 nm and carotenoids at
450 nm with the use of a photodiode array detector. Costs of the
assay include those required for HPLC maintenance, columns,
HPLC-grade reagents, consumable supplies, and salaries for
relatively skilled laboratory technicians who can run and
maintain the equipment, process the samples, and monitor the
quality of the assays over time.
Methods under development. Efforts are being made to
reduce the time required to assess serum retinol by making field-
ready devices. Limited data are currently available with respect
to their comparison to serum retinol with the use of traditional
HPLC. The CRAFTi is a portable device produced by Craft
Technologies that can assess retinol with 25 mL serum on the
basis of fluorescent properties and compared well with serum
retinol by HPLC (255). The iCheck is also a portable device
based on fluorescent properties of retinol. It uses 500 mL whole
blood, which eliminates sample processing, although it was
recently compared with HPLC with the use of 500 mL serum
(311).
Quality assurance and control. Serum standard reference
materials to ensure interlaboratory agreement with respect to
retinol and other related compounds are available through the
National Institute of Standards and Technology (312), and a
quality assurance testing program is available through the CDC
(313).
New Directions and Technologies
Biomarkers that are relatively noninvasive, respond to interven-
tions, and work along the entire continuum of vitamin A status
are needed. Aside from liver biopsy, isotope dilution methods are
the only indirect measure of vitamin A status that work along the
continuum. However, even isotope dilution may be limited in
groups of individuals who have high infection rates or co-
micronutrient deficiencies, and research gaps have been identi-
fied (314) (Table 9). Identifying what factors affect each of the
biomarkers is important to understanding their limitations in
clinical and population applications.
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Research Gaps and Needs
Although serum retinol concentrations have limitations, there
are still groups of individuals for whom serum retinol concen-
trations have not been well-defined. One of these groups is
young infants, where the reference range has not been defined for
an adequate population. RBP continues to increase as children
age; therefore, it may be that the cutoff for serum retinol
concentrations in young infants should be lower than in older
children. This should be determined against more sensitive
indicators of vitamin A status, such as isotope dilution testing.
Furthermore, after this reference range is determined, setting the
prevalence to define a public health problem is also necessary.
Although it is well known that inflammation and infection affect
serum retinol concentrations, questions still remain on how to
use this information when acute-phase proteins are measured
(35, 220, 225). Are there functional indicators that can be
applied to young infants to help to define this reference range?
An additional research need related to retinol and RBP involves
better defining the role of the apparent receptor protein for
plasma RBP, STRA6, with regard to its role in vitamin A uptake
by tissues at different levels of status, in different cell types, and
during the acute-phase response when serum retinol and RBP
decrease (315). For example, is transport to target tissues
somehow modulated via differential STRA6 expression?
Another research need is to help countries decide which
combination of biomarkers to use to inform programs. The
selection of these biomarkers needs to have reference values for
different age subgroups of the population and the prevalence of
deficiency that triggers the need for an intervention.
The association of serum retinol to breast-milk retinol con-
centrations needs to be better understood. Although it appears that
breast-milk concentrations may be less affected by infection and
inflammation, retinol delivery to the mammary gland on RBP
contributes to breast-milk concentration. Because serum retinol is
negatively affected by the acute-phase response, breast milk is
likely affected during severe serum retinol depression.
Vitamin A deficiency is defined by the risk of xerophthalmia
and the increased risk of death from infectious disease. The latter
risk is due, we presume, to impaired immune function in deficient
individuals. Some data suggest that increasing intake may affect
immune function through the range of vitamin A stores found in
healthy adults (316). It is thus plausible that immune markers may
vary across a continuum of vitamin A statuses from the adequate
range and into the range of chronic toxicity. The evaluation of
such effects may provide additional methods to determine the
impact of excess vitamin A intake.
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